550 lines
No EOL
278 KiB
HTML
550 lines
No EOL
278 KiB
HTML
<?xml version="1.0" encoding="utf-8"?>
|
|
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
|
|
|
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
|
<!-- AppResources meta begin -->
|
|
<meta name="paf-app-resources" content="" />
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- AppResources meta end -->
|
|
|
|
<!-- TemplateResources meta begin -->
|
|
<meta name="paf_template" content="" />
|
|
|
|
<!-- TemplateResources meta end -->
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-toc" /><meta name="ncbi_acc" content="NBK15127" /><meta name="ncbi_domain" content="hsnihcdc" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK15127/" /><meta name="ncbi_pagename" content="NIH Consensus Statements - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="toc" /><meta name="ncbi_app" content="bookshelf" />
|
|
<!-- Logger end -->
|
|
|
|
<title>NIH Consensus Statements - NCBI Bookshelf</title>
|
|
|
|
<!-- AppResources external_resources begin -->
|
|
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
|
|
|
<!-- AppResources external_resources end -->
|
|
|
|
<!-- Page meta begin -->
|
|
<meta name="robots" content="NOINDEX,NOFOLLOW,NOARCHIVE,NOIMAGEINDEX" /><meta name="author" content="National Institutes of Health (US). Office for Medical Applications of Research" /><meta name="citation_title" content="NIH Consensus Statements" /><meta name="citation_publisher" content="National Institutes of Health (US)" /><meta name="citation_date" content="2002" /><meta name="citation_author" content="National Institutes of Health (US). Office for Medical Applications of Research" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK15127/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="NIH Consensus Statements" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institutes of Health (US)" /><meta name="DC.Contributor" content="National Institutes of Health (US). Office for Medical Applications of Research" /><meta name="DC.Date" content="2002" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK15127/" /><meta name="DC.Language" content="en" /><meta name="description" content="The NIH Office of Medical Applications of Research (OMAR) manages the NIH Consensus Development Program, the focal point for evidence-based assessments of medical practice and state-of-the-science on behalf of the medical community and the public." /><meta name="og:title" content="NIH Consensus Statements" /><meta name="og:type" content="book" /><meta name="og:description" content="The NIH Office of Medical Applications of Research (OMAR) manages the NIH Consensus Development Program, the focal point for evidence-based assessments of medical practice and state-of-the-science on behalf of the medical community and the public." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK15127/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-hsnihcdc-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="warning" content="This publication is provided for historical reference only and the information may be out of date." /><meta name="bk-non-canon-loc" content="/books/n/hsnihcdc/toc/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK15127/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">.main-content {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/css/bookshelf/2.26/img/archive.png);background-size: auto, contain; padding:0 0 0 3em }</style><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} </style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script><meta name="book-collection" content="NONE" />
|
|
|
|
<!-- Page meta end -->
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8E72A57D5C15C10000000000C100AD.m_13" />
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/4207974/4206132/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
|
<body class="book-toc">
|
|
<div class="grid">
|
|
<div class="col twelve_col nomargin shadow">
|
|
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
|
<div class="sysmessages">
|
|
<noscript>
|
|
<p class="nojs">
|
|
<strong>Warning:</strong>
|
|
The NCBI web site requires JavaScript to function.
|
|
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
|
</p>
|
|
</noscript>
|
|
</div>
|
|
<!--/.sysmessage-->
|
|
<div class="wrap">
|
|
<div class="page">
|
|
<div class="top">
|
|
<div id="universal_header">
|
|
<section class="usa-banner">
|
|
<div class="usa-accordion">
|
|
<header class="usa-banner-header">
|
|
<div class="usa-grid usa-banner-inner">
|
|
<img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
|
|
<p>An official website of the United States government</p>
|
|
<button class="non-usa-accordion-button usa-banner-button" aria-expanded="false" aria-controls="gov-banner-top" type="button">
|
|
<span class="usa-banner-button-text">Here's how you know</span>
|
|
</button>
|
|
</div>
|
|
</header>
|
|
<div class="usa-banner-content usa-grid usa-accordion-content" id="gov-banner-top" aria-hidden="true">
|
|
<div class="usa-banner-guidance-gov usa-width-one-half">
|
|
<img class="usa-banner-icon usa-media_block-img" src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg" alt="Dot gov" />
|
|
<div class="usa-media_block-body">
|
|
<p>
|
|
<strong>The .gov means it's official.</strong>
|
|
<br />
|
|
Federal government websites often end in .gov or .mil. Before
|
|
sharing sensitive information, make sure you're on a federal
|
|
government site.
|
|
</p>
|
|
</div>
|
|
</div>
|
|
<div class="usa-banner-guidance-ssl usa-width-one-half">
|
|
<img class="usa-banner-icon usa-media_block-img" src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg" alt="Https" />
|
|
<div class="usa-media_block-body">
|
|
<p>
|
|
<strong>The site is secure.</strong>
|
|
<br />
|
|
The <strong>https://</strong> ensures that you are connecting to the
|
|
official website and that any information you provide is encrypted
|
|
and transmitted securely.
|
|
</p>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
</section>
|
|
<div class="usa-overlay"></div>
|
|
<header class="ncbi-header" role="banner" data-section="Header">
|
|
|
|
<div class="usa-grid">
|
|
<div class="usa-width-one-whole">
|
|
|
|
<div class="ncbi-header__logo">
|
|
<a href="/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
|
|
<img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
|
|
</a>
|
|
</div>
|
|
|
|
<div class="ncbi-header__account">
|
|
<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
|
|
<button id="account_info" class="header-button" style="display:none" aria-controls="account_popup" type="button">
|
|
<span class="fa fa-user" aria-hidden="true">
|
|
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" width="20px" height="20px">
|
|
<g style="fill: #fff">
|
|
<ellipse cx="12" cy="8" rx="5" ry="6"></ellipse>
|
|
<path d="M21.8,19.1c-0.9-1.8-2.6-3.3-4.8-4.2c-0.6-0.2-1.3-0.2-1.8,0.1c-1,0.6-2,0.9-3.2,0.9s-2.2-0.3-3.2-0.9 C8.3,14.8,7.6,14.7,7,15c-2.2,0.9-3.9,2.4-4.8,4.2C1.5,20.5,2.6,22,4.1,22h15.8C21.4,22,22.5,20.5,21.8,19.1z"></path>
|
|
</g>
|
|
</svg>
|
|
</span>
|
|
<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
|
|
<span class="sr-only">Show account info</span>
|
|
</button>
|
|
</div>
|
|
|
|
<div class="ncbi-popup-anchor">
|
|
<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
|
|
<div class="ncbi-popup-head">
|
|
<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu" type="button">
|
|
<span class="fa fa-times">
|
|
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" height="24px">
|
|
<path d="M38 12.83l-2.83-2.83-11.17 11.17-11.17-11.17-2.83 2.83 11.17 11.17-11.17 11.17 2.83 2.83 11.17-11.17 11.17 11.17 2.83-2.83-11.17-11.17z"></path>
|
|
</svg>
|
|
</span>
|
|
<span class="usa-sr-only">Close</span></button>
|
|
<h4>Account</h4>
|
|
</div>
|
|
<div class="account-user-info">
|
|
Logged in as:<br />
|
|
<b><span class="username" id="uname_long">username</span></b>
|
|
</div>
|
|
<div class="account-links">
|
|
<ul class="usa-unstyled-list">
|
|
<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
|
|
<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
|
|
<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
|
|
<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
|
|
</ul>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
|
|
</div>
|
|
</div>
|
|
</header>
|
|
<div role="navigation" aria-label="access keys">
|
|
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
|
|
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
|
|
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
|
|
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
|
|
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
|
|
</div>
|
|
<section data-section="Alerts">
|
|
<div class="ncbi-alerts-placeholder"></div>
|
|
</section>
|
|
</div>
|
|
<div class="header">
|
|
<div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
|
|
<div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" data-ac_dict="bookshelf-search">Books</option><option value="nlmcatalog">NLM Catalog</option><option value="pmc">PMC</option><option value="nuccore" class="last">Nucleotide</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
|
|
<a href="/books/browse/">Browse Titles</a>
|
|
</li><li>
|
|
<a href="/books/advanced/">Advanced</a>
|
|
</li><li class="help">
|
|
<a href="/books/NBK3833/">Help</a>
|
|
</li><li class="disclaimer">
|
|
<a target="_blank" data-ga-category="literature_resources" data-ga-action="link_click" data-ga-label="disclaimer_link" href="https://www.ncbi.nlm.nih.gov/books/about/disclaimer/">Disclaimer</a>
|
|
</li></ul></div>
|
|
</div>
|
|
|
|
|
|
|
|
<!--<component id="Page" label="headcontent"/>-->
|
|
|
|
</div>
|
|
<div class="content">
|
|
<!-- site messages -->
|
|
<!-- Custom content 1 -->
|
|
<div class="col1">
|
|
|
|
</div>
|
|
|
|
<div class="container">
|
|
<div id="maincontent" class="content eight_col col">
|
|
<!-- Custom content in the left column above book nav -->
|
|
<div class="col2">
|
|
|
|
</div>
|
|
|
|
<!-- Book content -->
|
|
|
|
|
|
<!-- Custom content between navigation and content -->
|
|
<div class="col3">
|
|
|
|
</div>
|
|
|
|
<div class="source">
|
|
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p></div><div class="messagearea bk_noprnt" style="margin-bottom:1.3846em "><ul class="messages"><li class="warn icon"><span class="icon">This publication is provided for historical reference only and the information may be out of date.</span></li></ul></div><div class="bk_prnt"><p style="color:red;"><strong>This publication is provided for historical reference only and the information may be out of date.</strong></p></div><div class="pagination bk_noprnt"><span class="inactive page_link prev">< Prev</span><a class="active page_link next" href="/books/n/hsnihcdc/A22074/" title="Next page in this title">Next ></a></div></div></div>
|
|
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/Book"><div class="meta-content fm-sec"><div class="iconblock whole_rhythm clearfix no_top_margin"><div class="left label"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-hsnihcdc-lrg.png" alt="Cover of NIH Consensus Statements" /></div><div class="icnblk_cntnt"><h1 id="_NBK15127_"><span itemprop="name">NIH Consensus Statements</span></h1><p class="contrib-group"><span itemprop="author">National Institutes of Health (US). Office for Medical Applications of Research</span>.</p><div class="half_rhythm">Bethesda (MD): <span itemprop="publisher">National Institutes of Health (US)</span>; 1977-<span itemprop="datePublished">2002</span>.</div><div class="half_rhythm"><ul class="inline_list"><li><span class="label"><a data-jig="ncbidialog" href="#_ncbi_dlg_cpyrght_NBK15127" data-jigconfig="modal:true">Copyright and
|
|
Permissions</a></span></li></ul></div><div id="_ncbi_dlg_cpyrght_NBK15127" style="display:none" title="Copyright and Permissions"><div>This publication is in the public domain. For more information, see the <a href="/books/about/copyright/">Bookshelf Copyright Notice</a>.</div></div></div></div></div><div class="body-content whole_rhythm" itemprop="text"><div itemprop="description"><p>The NIH Office of Medical Applications of Research (OMAR) manages the <a href="http://consensus.nih.gov" ref="pagearea=abstract&targetsite=external&targetcat=link&targettype=uri">NIH
|
|
Consensus Development Program</a>, the focal point for evidence-based
|
|
assessments of medical practice and state-of-the-science on behalf of the
|
|
medical community and the public.</p></div><div><h2>Contents</h2><div class="bktoc_all_cntnr top align_right" style="display:none"><ul class="inline_list_right"><li><a class="bktoc_all_exp" href="#">Expand All</a></li><li style="margin-left:.8em"><a class="bktoc_all_clps" href="#">Collapse All</a></li></ul></div><ul id="toc_tllNBK15127_A22074" class="simple-list toc toc-toggle"><li class="half_rhythm" id="toc_itm_NBK15127_A22074"><a href="/books/n/hsnihcdc/A22074/" class="toc-item">116. Management of Hepatitis C: National Institutes of Health Consensus Development Conference Statement June 10-12, 2002</a><ul id="toc_lst_NBK15127_A22076" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A22076"><a href="/books/n/hsnihcdc/A22074/#A22076" class="toc-item">
|
|
Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22083"><a href="/books/n/hsnihcdc/A22074/#A22083" class="toc-item">1. What is the natural history of hepatitis C?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22089"><a href="/books/n/hsnihcdc/A22074/#A22089" class="toc-item">2. What is the most appropriate approach to diagnose and monitor patients?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22098"><a href="/books/n/hsnihcdc/A22074/#A22098" class="toc-item">3. What is the most effective therapy for hepatitis C?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22103"><a href="/books/n/hsnihcdc/A22074/#A22103" class="toc-item">4. Which patients with hepatitis C should be treated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22113"><a href="/books/n/hsnihcdc/A22074/#A22113" class="toc-item">5. What recommendations can be made to patients to prevent transmission of hepatitis C?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22114"><a href="/books/n/hsnihcdc/A22074/#A22114" class="toc-item">6. What are the most important areas for future research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22136"><a href="/books/n/hsnihcdc/A22074/#A22136" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22137"><a href="/books/n/hsnihcdc/A22074/#A22137" class="toc-item">Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22150"><a href="/books/n/hsnihcdc/A22074/#A22150" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22222"><a href="/books/n/hsnihcdc/A22074/#A22222" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22399"><a href="/books/n/hsnihcdc/A22074/#A22399" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22593"><a href="/books/n/hsnihcdc/A22074/#A22593" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22598"><a href="/books/n/hsnihcdc/A22074/#A22598" class="toc-item">Conference Cosponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A21696"><a href="/books/n/hsnihcdc/A21696/" class="toc-item">115. Diagnosis and Management of Dental Caries Throughout Life: National Institutes of Health Consensus Development Conference Statement March 26-28, 2001</a><ul id="toc_lst_NBK15127_A21698" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A21698"><a href="/books/n/hsnihcdc/A21696/#A21698" class="toc-item">
|
|
Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21705"><a href="/books/n/hsnihcdc/A21696/#A21705" class="toc-item">
|
|
1. What are the best methods for detecting early and advanced dental
|
|
caries (validity and feasibility of traditional methods; validity and feasibility of emerging
|
|
methods)?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21706"><a href="/books/n/hsnihcdc/A21696/#A21706" class="toc-item">
|
|
2. What are the best indicators for an increased risk
|
|
of dental caries?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21707"><a href="/books/n/hsnihcdc/A21696/#A21707" class="toc-item">
|
|
3. What are the best methods available for the primary prevention of
|
|
dental caries initiation throughout life?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21708"><a href="/books/n/hsnihcdc/A21696/#A21708" class="toc-item">
|
|
4. What are the best treatments available for reversing or arresting
|
|
the progression of early dental caries?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21716"><a href="/books/n/hsnihcdc/A21696/#A21716" class="toc-item">
|
|
5. How should clinical decisions regarding prevention and/or treatment
|
|
be affected by detection methods and risk assessment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21717"><a href="/books/n/hsnihcdc/A21696/#A21717" class="toc-item">
|
|
6. What are promising new research directions for the prevention,
|
|
diagnosis, and treatment of dental caries?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21724"><a href="/books/n/hsnihcdc/A21696/#A21724" class="toc-item">
|
|
Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21725"><a href="/books/n/hsnihcdc/A21696/#A21725" class="toc-item">
|
|
Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21795"><a href="/books/n/hsnihcdc/A21696/#A21795" class="toc-item">
|
|
Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21973"><a href="/books/n/hsnihcdc/A21696/#A21973" class="toc-item">
|
|
Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22060"><a href="/books/n/hsnihcdc/A21696/#A22060" class="toc-item">
|
|
Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A22067"><a href="/books/n/hsnihcdc/A21696/#A22067" class="toc-item">
|
|
Conference Cosponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A21292"><a href="/books/n/hsnihcdc/A21292/" class="toc-item">114. Adjuvant Therapy for Breast Cancer: National Institutes of Health Consensus Development Conference Statement November 1-3, 2000</a><ul id="toc_lst_NBK15127_A21294" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A21294"><a href="/books/n/hsnihcdc/A21292/#A21294" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21301"><a href="/books/n/hsnihcdc/A21292/#A21301" class="toc-item">1. Which factors should be used to select systemic adjuvant therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21302"><a href="/books/n/hsnihcdc/A21292/#A21302" class="toc-item">2. For which patients should adjuvant hormonal therapy be recommended?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21303"><a href="/books/n/hsnihcdc/A21292/#A21303" class="toc-item">3. For which patients should adjuvant chemotherapy be recommended? Which agents should be used, and at what dose or schedule?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21304"><a href="/books/n/hsnihcdc/A21292/#A21304" class="toc-item">4. For which patients should post-mastectomy radiotherapy be recommended?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21305"><a href="/books/n/hsnihcdc/A21292/#A21305" class="toc-item">5. How do side effects and quality-of-life issues factor into individual decision-making about adjuvant therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21310"><a href="/books/n/hsnihcdc/A21292/#A21310" class="toc-item">6. What are promising new research directions for adjuvant therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21311"><a href="/books/n/hsnihcdc/A21292/#A21311" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21312"><a href="/books/n/hsnihcdc/A21292/#A21312" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21384"><a href="/books/n/hsnihcdc/A21292/#A21384" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21559"><a href="/books/n/hsnihcdc/A21292/#A21559" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21682"><a href="/books/n/hsnihcdc/A21292/#A21682" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21689"><a href="/books/n/hsnihcdc/A21292/#A21689" class="toc-item">Conference Cosponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A20932"><a href="/books/n/hsnihcdc/A20932/" class="toc-item">113. Phenylketonuria: Screening and Management: National Institutes of Health Consensus Development Conference Statement October 16-18, 2000</a><ul id="toc_lst_NBK15127_A20934" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A20934"><a href="/books/n/hsnihcdc/A20932/#A20934" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20940"><a href="/books/n/hsnihcdc/A20932/#A20940" class="toc-item">1. What are the incidence and prevalence of PKU and other forms of hyperphenylalaninemias, and what is known about the genetic and clinical variability?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20943"><a href="/books/n/hsnihcdc/A20932/#A20943" class="toc-item">2. What newborn screening strategies are available for diagnosis, what is the effectiveness of these strategies, and what cost-savings are generated by screening and treatment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20947"><a href="/books/n/hsnihcdc/A20932/#A20947" class="toc-item">3. What treatment regimens are used to prevent the adverse consequences of PKU? What is known about the effectiveness of these treatment and management strategies overall and with respect to variables, such as time of initiation of dietary management, levels of phenylalanine at various ages, methods for enhancing dietary compliance, duration of dietary management, and dietary regimens for women of childbearing age and other adults?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20951"><a href="/books/n/hsnihcdc/A20932/#A20951" class="toc-item">4. Based on this information, what are the recommended strategies for optimal newborn screening and diagnosis and lifelong management and followup of PKU?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20973"><a href="/books/n/hsnihcdc/A20932/#A20973" class="toc-item">5. What research is needed to gather information that will optimize the outcomes for individuals with PKU and their families?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20983"><a href="/books/n/hsnihcdc/A20932/#A20983" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20994"><a href="/books/n/hsnihcdc/A20932/#A20994" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21064"><a href="/books/n/hsnihcdc/A20932/#A21064" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21166"><a href="/books/n/hsnihcdc/A20932/#A21166" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21267"><a href="/books/n/hsnihcdc/A20932/#A21267" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A21274"><a href="/books/n/hsnihcdc/A20932/#A21274" class="toc-item">Conference Cosponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A20680"><a href="/books/n/hsnihcdc/A20680/" class="toc-item">112. Antenatal Corticosteroids Revisited: Repeat Courses: National Institutes of Health Consensus Development Conference Statement August 17-18, 2000</a><ul id="toc_lst_NBK15127_A20682" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A20682"><a href="/books/n/hsnihcdc/A20680/#A20682" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20686"><a href="/books/n/hsnihcdc/A20680/#A20686" class="toc-item">1. Is the evidence on benefits and risks of repeat courses of antenatal corticosteroids sufficient to permit consensus recommendations?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20690"><a href="/books/n/hsnihcdc/A20680/#A20690" class="toc-item">2. If so, what are the recommendations?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20694"><a href="/books/n/hsnihcdc/A20680/#A20694" class="toc-item">3. If not, what additional information should be obtained?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20704"><a href="/books/n/hsnihcdc/A20680/#A20704" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20708"><a href="/books/n/hsnihcdc/A20680/#A20708" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20803"><a href="/books/n/hsnihcdc/A20680/#A20803" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20879"><a href="/books/n/hsnihcdc/A20680/#A20879" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20922"><a href="/books/n/hsnihcdc/A20680/#A20922" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20927"><a href="/books/n/hsnihcdc/A20680/#A20927" class="toc-item">Conference Cosponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A20225"><a href="/books/n/hsnihcdc/A20225/" class="toc-item">111. Osteoporosis Prevention, Diagnosis, and Therapy: National Institutes of Health Consensus Development Conference Statement March 27-29, 2000</a><ul id="toc_lst_NBK15127_A20227" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A20227"><a href="/books/n/hsnihcdc/A20225/#A20227" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20233"><a href="/books/n/hsnihcdc/A20225/#A20233" class="toc-item">1. What is osteoporosis and what are its consequences?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20234"><a href="/books/n/hsnihcdc/A20225/#A20234" class="toc-item">2. How do risks vary among different segments of the population?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20240"><a href="/books/n/hsnihcdc/A20225/#A20240" class="toc-item">3. What factors are involved in building and maintaining skeletal health throughout life?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20245"><a href="/books/n/hsnihcdc/A20225/#A20245" class="toc-item">4. What is the optimal evaluation and treatment of osteoporosis and fractures?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20246"><a href="/books/n/hsnihcdc/A20225/#A20246" class="toc-item">Who Should Be Evaluated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20247"><a href="/books/n/hsnihcdc/A20225/#A20247" class="toc-item">What Are the Effective Medical Treatments?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20248"><a href="/books/n/hsnihcdc/A20225/#A20248" class="toc-item">Should the Response to Treatment Be Monitored?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20250"><a href="/books/n/hsnihcdc/A20225/#A20250" class="toc-item">5. What are the directions for future research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20270"><a href="/books/n/hsnihcdc/A20225/#A20270" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20287"><a href="/books/n/hsnihcdc/A20225/#A20287" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20354"><a href="/books/n/hsnihcdc/A20225/#A20354" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20526"><a href="/books/n/hsnihcdc/A20225/#A20526" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20656"><a href="/books/n/hsnihcdc/A20225/#A20656" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20661"><a href="/books/n/hsnihcdc/A20225/#A20661" class="toc-item">Conference Cosponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A19663"><a href="/books/n/hsnihcdc/A19663/" class="toc-item">110. Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder: National Institutes of Health Consensus Development Conference Statement November 16-18, 1998</a><ul id="toc_lst_NBK15127_A19671" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A19671"><a href="/books/n/hsnihcdc/A19663/#A19671" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19678"><a href="/books/n/hsnihcdc/A19663/#A19678" class="toc-item">1. What Is the Scientific Evidence To Support ADHD as a Disorder?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19684"><a href="/books/n/hsnihcdc/A19663/#A19684" class="toc-item">2. What Is the Impact of ADHD on Individuals, Families, and Society?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19685"><a href="/books/n/hsnihcdc/A19663/#A19685" class="toc-item">3. What Are the Effective Treatments for ADHD?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19686"><a href="/books/n/hsnihcdc/A19663/#A19686" class="toc-item">
|
|
4. What Are the Risks of the Use of Stimulant Medication and Other Treatments?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19687"><a href="/books/n/hsnihcdc/A19663/#A19687" class="toc-item">5. What Are the Existing Diagnostic and Treatment Practices, and What Are the Barriers to Appropriate Identification, Evaluation, and Intervention?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19689"><a href="/books/n/hsnihcdc/A19663/#A19689" class="toc-item">6. What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19701"><a href="/books/n/hsnihcdc/A19663/#A19701" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19702"><a href="/books/n/hsnihcdc/A19663/#A19702" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19770"><a href="/books/n/hsnihcdc/A19663/#A19770" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19941"><a href="/books/n/hsnihcdc/A19663/#A19941" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20093"><a href="/books/n/hsnihcdc/A19663/#A20093" class="toc-item">Lead Organizations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20103"><a href="/books/n/hsnihcdc/A19663/#A20103" class="toc-item">Supporting Organizations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20117"><a href="/books/n/hsnihcdc/A19663/#A20117" class="toc-item">Bibliography</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A19146"><a href="/books/n/hsnihcdc/A19146/" class="toc-item">109. Rehabilitation of Persons with Traumatic Brain Injury: National Institutes of Health Consensus Development Conference Statement October 26-28, 1998</a><ul id="toc_lst_NBK15127_A19154" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A19154"><a href="/books/n/hsnihcdc/A19146/#A19154" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19162"><a href="/books/n/hsnihcdc/A19146/#A19162" class="toc-item">1. What Is the Epidemiology of Traumatic Brain Injury in the United States, and What Are Its Implications for Rehabilitation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19163"><a href="/books/n/hsnihcdc/A19146/#A19163" class="toc-item">2. What Are the Consequences of Traumatic Brain Injury in Terms of Pathophysiology, Impairments, Functional Limitations, Disabilities, Societal Limitations, and Economic Impact?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19164"><a href="/books/n/hsnihcdc/A19146/#A19164" class="toc-item">3. What Is Known About Mechanisms Underlying Functional Recovery Following TBI, and What Are the Implications for Rehabilitation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19165"><a href="/books/n/hsnihcdc/A19146/#A19165" class="toc-item">
|
|
4. What Are the Common Therapeutic Interventions for the Cognitive and Behavioral Sequelae of TBI, What Is Their Scientific Basis, and How Effective Are They?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19166"><a href="/books/n/hsnihcdc/A19146/#A19166" class="toc-item">5. What Are Common Models of Comprehensive, Coordinated, Multidisciplinary Rehabilitation for People With TBI, What Is Their Scientific Basis, and What Is Known About Their Short-Term and Long-Term Outcomes?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19167"><a href="/books/n/hsnihcdc/A19146/#A19167" class="toc-item">6. Based on the Answers to These Questions, What Can Be Recommended Regarding Rehabilitation Practices for People With TBI?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19183"><a href="/books/n/hsnihcdc/A19146/#A19183" class="toc-item">7. What Research Is Needed to Guide the Rehabilitation of People With TBI?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19214"><a href="/books/n/hsnihcdc/A19146/#A19214" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19228"><a href="/books/n/hsnihcdc/A19146/#A19228" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19311"><a href="/books/n/hsnihcdc/A19146/#A19311" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19441"><a href="/books/n/hsnihcdc/A19146/#A19441" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19579"><a href="/books/n/hsnihcdc/A19146/#A19579" class="toc-item">Lead Organizations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19586"><a href="/books/n/hsnihcdc/A19146/#A19586" class="toc-item">Supporting Organizations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19595"><a href="/books/n/hsnihcdc/A19146/#A19595" class="toc-item">Bibliography</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A18649"><a href="/books/n/hsnihcdc/A18649/" class="toc-item">108. Effective Medical Treatment of Opiate Addiction: National Institutes of Health Consensus Development Conference Statement November 17-19, 1997</a><ul id="toc_lst_NBK15127_A18657" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A18657"><a href="/books/n/hsnihcdc/A18649/#A18657" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18663"><a href="/books/n/hsnihcdc/A18649/#A18663" class="toc-item">1. What Is the Scientific Evidence to Support a Conceptualization of Opiate Dependence as a Medical Disorder Including Natural History, Genetics and Risk Factors, and Pathophysiology, and How Is Diagnosis Established?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18674"><a href="/books/n/hsnihcdc/A18649/#A18674" class="toc-item">2. What Are the Consequences of Untreated Opiate Dependence to Individuals, Families, and Society?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18681"><a href="/books/n/hsnihcdc/A18649/#A18681" class="toc-item">3. What Is the Efficacy of Current Treatment Modalities in the Management of Opiate Dependence Including Detoxification Alone, Nonpharmacological/Psychosocial Treatment, Treatment With Opiate Antagonists, and Treatment With Opiate Agonists (Short Term and Long Term)? And, What Is the Scientific Evidence for the Most Effective Use of Opiate Agonists in the Treatment of Opiate Dependence?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18686"><a href="/books/n/hsnihcdc/A18649/#A18686" class="toc-item"> 4. What Are the Important Barriers to Effective Use of Opiate Agonists in the Treatment of Opiate Addiction in the United States, Including Perceptions and the Adverse Consequences of Opiate Agonist Use and Legal, Regulatory, Financial, and Programmatic Barriers?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18695"><a href="/books/n/hsnihcdc/A18649/#A18695" class="toc-item">5. What Are the Future Research Areas and Recommendations for Improving Opiate Agonist Treatment and Improving Access?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18713"><a href="/books/n/hsnihcdc/A18649/#A18713" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18725"><a href="/books/n/hsnihcdc/A18649/#A18725" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18784"><a href="/books/n/hsnihcdc/A18649/#A18784" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18929"><a href="/books/n/hsnihcdc/A18649/#A18929" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19068"><a href="/books/n/hsnihcdc/A18649/#A19068" class="toc-item">Lead Organizations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19075"><a href="/books/n/hsnihcdc/A18649/#A19075" class="toc-item">Supporting Organization</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19079"><a href="/books/n/hsnihcdc/A18649/#A19079" class="toc-item">Bibliography</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A18129"><a href="/books/n/hsnihcdc/A18129/" class="toc-item">107. Acupuncture: National Institutes of Health Consensus Development Conference Statement November 3-5, 1997</a><ul id="toc_lst_NBK15127_A18137" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A18137"><a href="/books/n/hsnihcdc/A18129/#A18137" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18143"><a href="/books/n/hsnihcdc/A18129/#A18143" class="toc-item">1. What Is the Efficacy of Acupuncture, Compared With Placebo or Sham Acupuncture, in the Conditions for Which Sufficient Data Are Available to Evaluate?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18147"><a href="/books/n/hsnihcdc/A18129/#A18147" class="toc-item">2. What Is the Place of Acupuncture in the Treatment of Various Conditions for Which Sufficient Data Are Available, in Comparison or in Combination With Other Interventions (Including No Intervention)?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18148"><a href="/books/n/hsnihcdc/A18129/#A18148" class="toc-item">3. What Is Known About the Biological Effects of Acupuncture That Helps Us Understand How It Works?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18149"><a href="/books/n/hsnihcdc/A18129/#A18149" class="toc-item">4. What Issues Need To Be Addressed So That Acupuncture Can Be Appropriately Incorporated Into Today's Health Care System?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18150"><a href="/books/n/hsnihcdc/A18129/#A18150" class="toc-item">5. What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18158"><a href="/books/n/hsnihcdc/A18129/#A18158" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18159"><a href="/books/n/hsnihcdc/A18129/#A18159" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18215"><a href="/books/n/hsnihcdc/A18129/#A18215" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18363"><a href="/books/n/hsnihcdc/A18129/#A18363" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18553"><a href="/books/n/hsnihcdc/A18129/#A18553" class="toc-item">Lead Organizations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18560"><a href="/books/n/hsnihcdc/A18129/#A18560" class="toc-item">Supporting Organizations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18582"><a href="/books/n/hsnihcdc/A18129/#A18582" class="toc-item">Bibliography</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A17667"><a href="/books/n/hsnihcdc/A17667/" class="toc-item">106. Genetic Testing for Cystic Fibrosis: National Institutes of Health Consensus Development Conference Statement Apr 14-16, 1997</a><ul id="toc_lst_NBK15127_A17675" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A17675"><a href="/books/n/hsnihcdc/A17667/#A17675" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17681"><a href="/books/n/hsnihcdc/A17667/#A17681" class="toc-item">1. What Is the Current State of Knowledge Regarding Natural History, Epidemiology, Genotype-Phenotype Correlations, Treatment, and Genetic Testing of Cystic Fibrosis in Various Populations?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17689"><a href="/books/n/hsnihcdc/A17667/#A17689" class="toc-item">2. What Has Been Learned About Genetic Testing for Cystic Fibrosis Regarding (Public and Health Professional) Knowledge and Attitudes, Interest and Demand, Risks and Benefits, Effectiveness, Cost, and Impact?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17695"><a href="/books/n/hsnihcdc/A17667/#A17695" class="toc-item">3. Should Cystic Fibrosis Carrier Testing Be Offered to: (1) Individuals With a Family History of Cystic Fibrosis, (2) Adults in the Preconception or Prenatal Period, and/or (3) the General Population?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17701"><a href="/books/n/hsnihcdc/A17667/#A17701" class="toc-item">4. What Are the Optimal Practices for Cystic Fibrosis Genetic Testing (Setting, Timing, and the Practices of Education, Consent, and Counseling)?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17719"><a href="/books/n/hsnihcdc/A17667/#A17719" class="toc-item">5. What Should Be the Future Directions for Research Relevant to Genetic Testing for Cystic Fibrosis and, More Broadly, for Research and Health Policies Related to Genetic Testing?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17731"><a href="/books/n/hsnihcdc/A17667/#A17731" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17743"><a href="/books/n/hsnihcdc/A17667/#A17743" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17820"><a href="/books/n/hsnihcdc/A17667/#A17820" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17964"><a href="/books/n/hsnihcdc/A17667/#A17964" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18092"><a href="/books/n/hsnihcdc/A17667/#A18092" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18099"><a href="/books/n/hsnihcdc/A17667/#A18099" class="toc-item">Conference Cosponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A17218"><a href="/books/n/hsnihcdc/A17218/" class="toc-item">105. Management of Hepatitis C: National Institutes of Health Consensus Development Conference Statement March 24-26, 1997</a><ul id="toc_lst_NBK15127_A17226" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A17226"><a href="/books/n/hsnihcdc/A17218/#A17226" class="toc-item">
|
|
Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17233"><a href="/books/n/hsnihcdc/A17218/#A17233" class="toc-item">
|
|
1. What Is the Natural History of Hepatitis C?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17242"><a href="/books/n/hsnihcdc/A17218/#A17242" class="toc-item">
|
|
2. What Is the Most Appropriate Approach to Diagnose and Monitor Patients?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17243"><a href="/books/n/hsnihcdc/A17218/#A17243" class="toc-item">
|
|
3. What Is the Most Effective Therapy for Hepatitis C?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17244"><a href="/books/n/hsnihcdc/A17218/#A17244" class="toc-item">
|
|
4. Which Patients With Hepatitis C Should Be Treated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17245"><a href="/books/n/hsnihcdc/A17218/#A17245" class="toc-item">
|
|
5. What Recommendations Can Be Made to Patients to Prevent Transmission of Hepatitis C?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17246"><a href="/books/n/hsnihcdc/A17218/#A17246" class="toc-item">
|
|
6. What Are the Most Important Areas for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17256"><a href="/books/n/hsnihcdc/A17218/#A17256" class="toc-item">
|
|
Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17276"><a href="/books/n/hsnihcdc/A17218/#A17276" class="toc-item">
|
|
Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17343"><a href="/books/n/hsnihcdc/A17218/#A17343" class="toc-item">
|
|
Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17509"><a href="/books/n/hsnihcdc/A17218/#A17509" class="toc-item">
|
|
Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17647"><a href="/books/n/hsnihcdc/A17218/#A17647" class="toc-item">
|
|
Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17654"><a href="/books/n/hsnihcdc/A17218/#A17654" class="toc-item">
|
|
Conference Cosponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A16786"><a href="/books/n/hsnihcdc/A16786/" class="toc-item">104. Interventions To Prevent HIV Risk Behaviors: National Institutes of Health Consensus Development Conference Statement February 11-13, 1997</a><ul id="toc_lst_NBK15127_A16794" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A16794"><a href="/books/n/hsnihcdc/A16786/#A16794" class="toc-item">
|
|
Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16800"><a href="/books/n/hsnihcdc/A16786/#A16800" class="toc-item">
|
|
1. How Can We Identify the Behaviors and Contexts That Place Individuals/Communities at Risk for HIV?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16805"><a href="/books/n/hsnihcdc/A16786/#A16805" class="toc-item">
|
|
2. What Individual-, Group-, or Community-based Methods of Intervention Reduce Behavioral Risks? What Are the Benefits and Risks of These Procedures?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16821"><a href="/books/n/hsnihcdc/A16786/#A16821" class="toc-item">
|
|
3. Does a Reduction in These Behavioral Risks Lead to a Reduction in HIV?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16826"><a href="/books/n/hsnihcdc/A16786/#A16826" class="toc-item">
|
|
4. How Can Risk-Reduction Procedures Be Implemented Effectively?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16839"><a href="/books/n/hsnihcdc/A16786/#A16839" class="toc-item">
|
|
5. What Research Is Most Urgently Needed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16845"><a href="/books/n/hsnihcdc/A16786/#A16845" class="toc-item">
|
|
Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16854"><a href="/books/n/hsnihcdc/A16786/#A16854" class="toc-item">
|
|
Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16923"><a href="/books/n/hsnihcdc/A16786/#A16923" class="toc-item">
|
|
Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17040"><a href="/books/n/hsnihcdc/A16786/#A17040" class="toc-item">
|
|
Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17180"><a href="/books/n/hsnihcdc/A16786/#A17180" class="toc-item">
|
|
Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17187"><a href="/books/n/hsnihcdc/A16786/#A17187" class="toc-item">
|
|
Conference Cosponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A16261"><a href="/books/n/hsnihcdc/A16261/" class="toc-item">103. Breast Cancer Screening for Women Ages 40-49: National Institutes of Health Consensus Development Conference Statement Jan 21-23, 1997</a><ul id="toc_lst_NBK15127_A16263" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A16263"><a href="/books/n/hsnihcdc/A16261/#A16263" class="toc-item">Foreword</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16273"><a href="/books/n/hsnihcdc/A16261/#A16273" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16279"><a href="/books/n/hsnihcdc/A16261/#A16279" class="toc-item">1. Is There a Reduction in Mortality From Breast Cancer Due to Screening Women Ages 40-49 With Mammography, With or Without Physical Examination? How Large is the Benefit? How Does This Change With Age?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16280"><a href="/books/n/hsnihcdc/A16261/#A16280" class="toc-item">2. What Are the Risks Associated With Screening Women Ages 40-49 With Mammography, and With Physical Examination? How Large Are the Risks? How Do they Change With Age?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16286"><a href="/books/n/hsnihcdc/A16261/#A16286" class="toc-item">3. Are There Other Benefits? If So, What Are They? How Do They Change With Age?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16287"><a href="/books/n/hsnihcdc/A16261/#A16287" class="toc-item">4. What Is Known About How the Benefits and Risks of Breast Cancer Screening Differ Based on Known Risk Factors for Breast Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16288"><a href="/books/n/hsnihcdc/A16261/#A16288" class="toc-item">5. What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16307"><a href="/books/n/hsnihcdc/A16261/#A16307" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16308"><a href="/books/n/hsnihcdc/A16261/#A16308" class="toc-item">Minority Report</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16315"><a href="/books/n/hsnihcdc/A16261/#A16315" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16375"><a href="/books/n/hsnihcdc/A16261/#A16375" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16580"><a href="/books/n/hsnihcdc/A16261/#A16580" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16769"><a href="/books/n/hsnihcdc/A16261/#A16769" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16776"><a href="/books/n/hsnihcdc/A16261/#A16776" class="toc-item">Conference Cosponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A15709"><a href="/books/n/hsnihcdc/A15709/" class="toc-item">102. Cervical Cancer: National Institutes of Health Consensus Development Conference Statement April 1-3, 1996</a><ul id="toc_lst_NBK15127_A15712" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A15712"><a href="/books/n/hsnihcdc/A15709/#A15712" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15717"><a href="/books/n/hsnihcdc/A15709/#A15717" class="toc-item">1. How Can We Strengthen Efforts To Prevent Cervical Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15723"><a href="/books/n/hsnihcdc/A15709/#A15723" class="toc-item">2. What Is the Appropriate Management of Low-Stage Cervical Cancer (FIGO Stages I-IIA)?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15724"><a href="/books/n/hsnihcdc/A15709/#A15724" class="toc-item">3. What Is the Appropriate Management of Advanced-Stage and Recurrent Cervical Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15728"><a href="/books/n/hsnihcdc/A15709/#A15728" class="toc-item">4. What Are New Directions for Research in Cervical Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15729"><a href="/books/n/hsnihcdc/A15709/#A15729" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15737"><a href="/books/n/hsnihcdc/A15709/#A15737" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15810"><a href="/books/n/hsnihcdc/A15709/#A15810" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15989"><a href="/books/n/hsnihcdc/A15709/#A15989" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16142"><a href="/books/n/hsnihcdc/A15709/#A16142" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16149"><a href="/books/n/hsnihcdc/A15709/#A16149" class="toc-item">Conference Cosponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A16179"><a href="/books/n/hsnihcdc/A15709/#A16179" class="toc-item">Bibliography</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A15154"><a href="/books/n/hsnihcdc/A15154/" class="toc-item">101. Physical Activity and Cardiovascular Health: National Institutes of Health Consensus Development Conference Statement December 18-20, 1995</a><ul id="toc_lst_NBK15127_A15157" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A15157"><a href="/books/n/hsnihcdc/A15154/#A15157" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15163"><a href="/books/n/hsnihcdc/A15154/#A15163" class="toc-item">1. What Is the Health Burden of a Sedentary Lifestyle on the Population?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15164"><a href="/books/n/hsnihcdc/A15154/#A15164" class="toc-item">2. What Type, What Intensity, and What Quantity of Physical Activity Are Important To Prevent Cardiovascular Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15165"><a href="/books/n/hsnihcdc/A15154/#A15165" class="toc-item">3. What Are the Benefits and Risks of Different Types of Physical Activity for People With Cardiovascular Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15166"><a href="/books/n/hsnihcdc/A15154/#A15166" class="toc-item">4. What Are the Successful Approaches To Adopting and Maintaining a Physically Active Lifestyle?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15181"><a href="/books/n/hsnihcdc/A15154/#A15181" class="toc-item">5. What Are the Important Considerations for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15188"><a href="/books/n/hsnihcdc/A15154/#A15188" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15192"><a href="/books/n/hsnihcdc/A15154/#A15192" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15260"><a href="/books/n/hsnihcdc/A15154/#A15260" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15453"><a href="/books/n/hsnihcdc/A15154/#A15453" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15598"><a href="/books/n/hsnihcdc/A15154/#A15598" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15605"><a href="/books/n/hsnihcdc/A15154/#A15605" class="toc-item">Conference Cosponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15633"><a href="/books/n/hsnihcdc/A15154/#A15633" class="toc-item">Bibliography</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A14810"><a href="/books/n/hsnihcdc/A14810/" class="toc-item">100. Cochlear Implants in Adults and Children: National Institutes of Health Consensus Development Conference Statement May
|
|
15-17, 1995</a><ul id="toc_lst_NBK15127_A14819" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A14819"><a href="/books/n/hsnihcdc/A14810/#A14819" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14825"><a href="/books/n/hsnihcdc/A14810/#A14825" class="toc-item">1. What Factors Affect the Auditory Performance of Cochlear Implant Recipients?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14834"><a href="/books/n/hsnihcdc/A14810/#A14834" class="toc-item">2. What Are the Benefits and Limitations of Cochlear Implantation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14840"><a href="/books/n/hsnihcdc/A14810/#A14840" class="toc-item">3. What Are the Technical and Safety Considerations of Cochlear Implantation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14844"><a href="/books/n/hsnihcdc/A14810/#A14844" class="toc-item">4. Who Is a Candidate for Cochlear Implantation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14853"><a href="/books/n/hsnihcdc/A14810/#A14853" class="toc-item">5. What Are the Directions for Future Research on Cochlear Implantation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14861"><a href="/books/n/hsnihcdc/A14810/#A14861" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14871"><a href="/books/n/hsnihcdc/A14810/#A14871" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14931"><a href="/books/n/hsnihcdc/A14810/#A14931" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15068"><a href="/books/n/hsnihcdc/A14810/#A15068" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15134"><a href="/books/n/hsnihcdc/A14810/#A15134" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A15141"><a href="/books/n/hsnihcdc/A14810/#A15141" class="toc-item">Cosponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A14487"><a href="/books/n/hsnihcdc/A14487/" class="toc-item">99. Infectious Disease Testing for Blood Transfusions: National Institutes of Health Consensus Development Conference Statement January 9-12, 1995</a><ul id="toc_lst_NBK15127_A14496" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A14496"><a href="/books/n/hsnihcdc/A14487/#A14496" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14504"><a href="/books/n/hsnihcdc/A14487/#A14504" class="toc-item">To What Extent Does the Alanine Aminotransferase Test Contribute to Transfusion Safety; Should Its Use as in Current Practice Continue or Should Its Use Be Modified?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14509"><a href="/books/n/hsnihcdc/A14487/#A14509" class="toc-item">To What Extent Do Tests for Hepatitis B Core Antibody and for Syphilis Contribute to Transfusion Safety? Should Their Use as in Current Practice continue or Should Their Use Be Modified?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14516"><a href="/books/n/hsnihcdc/A14487/#A14516" class="toc-item">What Are the Appropriate Ways To Manage Potential Threats to Transfusion Safety From Emerging Infectious Diseases, Considered in Terms of Identification of Important Diseases, Changes in Blood Donor Screening Practices, and Introduction of New Laboratory Tests?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14526"><a href="/books/n/hsnihcdc/A14487/#A14526" class="toc-item">What Are the Highest Priorities for Research To Improve Transfusion Safety by Reducing the Transmission of Infectious Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14540"><a href="/books/n/hsnihcdc/A14487/#A14540" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14546"><a href="/books/n/hsnihcdc/A14487/#A14546" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14600"><a href="/books/n/hsnihcdc/A14487/#A14600" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14731"><a href="/books/n/hsnihcdc/A14487/#A14731" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14796"><a href="/books/n/hsnihcdc/A14487/#A14796" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14803"><a href="/books/n/hsnihcdc/A14487/#A14803" class="toc-item">Cosponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A14141"><a href="/books/n/hsnihcdc/A14141/" class="toc-item">98. Total Hip Replacement: National Institutes of Health Consensus Development Conference Statement September 12-14, 1994</a><ul id="toc_lst_NBK15127_A14150" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A14150"><a href="/books/n/hsnihcdc/A14141/#A14150" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14157"><a href="/books/n/hsnihcdc/A14141/#A14157" class="toc-item">What Are the Current Indications for Total Hip Replacement?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14158"><a href="/books/n/hsnihcdc/A14141/#A14158" class="toc-item">What Are the Design and Surgical Considerations Relating to a Replacement Prosthesis?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14159"><a href="/books/n/hsnihcdc/A14141/#A14159" class="toc-item">What Are the Responses of the Biological Environment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14160"><a href="/books/n/hsnihcdc/A14141/#A14160" class="toc-item">What Are the Expected Outcomes?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14161"><a href="/books/n/hsnihcdc/A14141/#A14161" class="toc-item">What Are the Accepted Approaches and Outcomes for Revision of a Total Hip Replacement?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14162"><a href="/books/n/hsnihcdc/A14141/#A14162" class="toc-item">What Are the Most Productive Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14163"><a href="/books/n/hsnihcdc/A14141/#A14163" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14171"><a href="/books/n/hsnihcdc/A14141/#A14171" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14238"><a href="/books/n/hsnihcdc/A14141/#A14238" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14406"><a href="/books/n/hsnihcdc/A14141/#A14406" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14479"><a href="/books/n/hsnihcdc/A14141/#A14479" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A13595"><a href="/books/n/hsnihcdc/A13595/" class="toc-item">97. Optimal Calcium Intake: National Institutes of Health Consensus Development Conference Statement June 6-8, 1994</a><ul id="toc_lst_NBK15127_A13604" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A13604"><a href="/books/n/hsnihcdc/A13595/#A13604" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13611"><a href="/books/n/hsnihcdc/A13595/#A13611" class="toc-item">1. What Is the Optimal Amount of Calcium Intake?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13618"><a href="/books/n/hsnihcdc/A13595/#A13618" class="toc-item">2. What Are the Important Cofactors for Achieving Optimal Calcium Intake?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13621"><a href="/books/n/hsnihcdc/A13595/#A13621" class="toc-item">3. What Are the Risks Associated With Increased Levels of Calcium Intake?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13622"><a href="/books/n/hsnihcdc/A13595/#A13622" class="toc-item">4. What Are the Best Ways To Attain Optimal Calcium Intake?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13623"><a href="/books/n/hsnihcdc/A13595/#A13623" class="toc-item">5. What Public Health Strategies Are Available and Needed To Implement Optimal Calcium Intake Recommendations?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13645"><a href="/books/n/hsnihcdc/A13595/#A13645" class="toc-item">6. What Are the Recommendations for Future Research on Calcium Intake?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13659"><a href="/books/n/hsnihcdc/A13595/#A13659" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13666"><a href="/books/n/hsnihcdc/A13595/#A13666" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13763"><a href="/books/n/hsnihcdc/A13595/#A13763" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13982"><a href="/books/n/hsnihcdc/A13595/#A13982" class="toc-item">Discussants</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13996"><a href="/books/n/hsnihcdc/A13595/#A13996" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A14132"><a href="/books/n/hsnihcdc/A13595/#A14132" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A13150"><a href="/books/n/hsnihcdc/A13150/" class="toc-item">96. Ovarian Cancer: Screening, Treatment, and Followup: National Institutes of Health Consensus Development Conference Statement April 5-7, 1994</a><ul id="toc_lst_NBK15127_A13153" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A13153"><a href="/books/n/hsnihcdc/A13150/#A13153" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13159"><a href="/books/n/hsnihcdc/A13150/#A13159" class="toc-item">What Is the Current Status of Screening and Prevention of Ovarian Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13165"><a href="/books/n/hsnihcdc/A13150/#A13165" class="toc-item">What Is the Appropriate Management of Early-Stage Ovarian Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13185"><a href="/books/n/hsnihcdc/A13150/#A13185" class="toc-item">What Is the Appropriate Management of Advanced Epithelial Ovarian Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13191"><a href="/books/n/hsnihcdc/A13150/#A13191" class="toc-item">What Is Appropriate Followup After Primary Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13193"><a href="/books/n/hsnihcdc/A13150/#A13193" class="toc-item">What Are Important Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13206"><a href="/books/n/hsnihcdc/A13150/#A13206" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13223"><a href="/books/n/hsnihcdc/A13150/#A13223" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13297"><a href="/books/n/hsnihcdc/A13150/#A13297" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13463"><a href="/books/n/hsnihcdc/A13150/#A13463" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13586"><a href="/books/n/hsnihcdc/A13150/#A13586" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A12756"><a href="/books/n/hsnihcdc/A12756/" class="toc-item">95. The Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes: National Institutes of Health Consensus Development Conference StatementFebruary 28-March 2, 1994</a><ul id="toc_lst_NBK15127_A12759" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A12759"><a href="/books/n/hsnihcdc/A12756/#A12759" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12767"><a href="/books/n/hsnihcdc/A12756/#A12767" class="toc-item">For What Conditions and Purposes Are Antenatal Cortico-Steroids Used, and What Is the Scientific Basis for That Use?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12782"><a href="/books/n/hsnihcdc/A12756/#A12782" class="toc-item">What Are the Short-Term and Long-Term Benefits of Antenatal Corticosteroid Treatment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12786"><a href="/books/n/hsnihcdc/A12756/#A12786" class="toc-item">What Are the Short-Term and Long-Term Adverse Effects for the Infant and Mother?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12790"><a href="/books/n/hsnihcdc/A12756/#A12790" class="toc-item">What Is the Influence of the Type of Corticosteroid, Dosage, Timing and Circumstances of Administration, and Associated Therapy on Treatment Outcome?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12803"><a href="/books/n/hsnihcdc/A12756/#A12803" class="toc-item">What Are the Economic Consequences of This Treatment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12804"><a href="/books/n/hsnihcdc/A12756/#A12804" class="toc-item">What Are the Recommendations for Use of Antenatal Corticosteroids?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12813"><a href="/books/n/hsnihcdc/A12756/#A12813" class="toc-item">What Research Is Needed To Guide Clinical Care?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12823"><a href="/books/n/hsnihcdc/A12756/#A12823" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12824"><a href="/books/n/hsnihcdc/A12756/#A12824" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12913"><a href="/books/n/hsnihcdc/A12756/#A12913" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13040"><a href="/books/n/hsnihcdc/A12756/#A13040" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A13139"><a href="/books/n/hsnihcdc/A12756/#A13139" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A12477"><a href="/books/n/hsnihcdc/A12477/" class="toc-item">94.
|
|
<i>Helicobacter pylori</i> in Peptic Ulcer Disease: National Institutes of Health Consensus Development Conference Statement February 7-9, 1994</a><ul id="toc_lst_NBK15127_A12480" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A12480"><a href="/books/n/hsnihcdc/A12477/#A12480" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12487"><a href="/books/n/hsnihcdc/A12477/#A12487" class="toc-item">What Is the Causal Relationship of <i> H. Pylori</i> to Upper Gastrointestinal Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12491"><a href="/books/n/hsnihcdc/A12477/#A12491" class="toc-item">How Does One Diagnose and Eradicate <i> H. Pylori</i> Infection?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12492"><a href="/books/n/hsnihcdc/A12477/#A12492" class="toc-item">Does Eradication of <i> H. Pylori</i> Infection Benefit the Patient With Peptic Ulcer Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12493"><a href="/books/n/hsnihcdc/A12477/#A12493" class="toc-item">What Is the Relationship Between <i> H. Pylori</i> Infection and Gastric Malignancy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12494"><a href="/books/n/hsnihcdc/A12477/#A12494" class="toc-item">Which <i>H. Pylori</i>-Infected Patients Should Be Treated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12496"><a href="/books/n/hsnihcdc/A12477/#A12496" class="toc-item">What Are the Most Important Questions That Must Be Addressed by Future Research in <i> H. Pylori</i> Infections?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12497"><a href="/books/n/hsnihcdc/A12477/#A12497" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12501"><a href="/books/n/hsnihcdc/A12477/#A12501" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12560"><a href="/books/n/hsnihcdc/A12477/#A12560" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12675"><a href="/books/n/hsnihcdc/A12477/#A12675" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12746"><a href="/books/n/hsnihcdc/A12477/#A12746" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A12077"><a href="/books/n/hsnihcdc/A12077/" class="toc-item">93. Morbidity and Mortality of Dialysis: National Institutes of Health Consensus Development Conference Statement November 1-3, 1993</a><ul id="toc_lst_NBK15127_A12080" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A12080"><a href="/books/n/hsnihcdc/A12077/#A12080" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12086"><a href="/books/n/hsnihcdc/A12077/#A12086" class="toc-item">How Does Early Medical Intervention in Predialysis Patients Influence Morbidity and Mortality?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12094"><a href="/books/n/hsnihcdc/A12077/#A12094" class="toc-item">What is the Relationship Between Delivered Dialysis Dose and Morbidity/Mortality?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12103"><a href="/books/n/hsnihcdc/A12077/#A12103" class="toc-item">Can Comorbid Conditions Be Altered by Nondialytic Interventions To Improve Morbidity/Mortality in Dialysis Patients?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12106"><a href="/books/n/hsnihcdc/A12077/#A12106" class="toc-item">How Can Dialysis-Related Complications Be Reduced?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12115"><a href="/books/n/hsnihcdc/A12077/#A12115" class="toc-item">What Are the Future Directions for Research in Dialysis?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12131"><a href="/books/n/hsnihcdc/A12077/#A12131" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12147"><a href="/books/n/hsnihcdc/A12077/#A12147" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12216"><a href="/books/n/hsnihcdc/A12077/#A12216" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12379"><a href="/books/n/hsnihcdc/A12077/#A12379" class="toc-item">Discussant</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12384"><a href="/books/n/hsnihcdc/A12077/#A12384" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12470"><a href="/books/n/hsnihcdc/A12077/#A12470" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A11796"><a href="/books/n/hsnihcdc/A11796/" class="toc-item">92. Early Identification of Hearing Impairment in Infants and Young Children: National Institutes of Health Consensus Development Conference Statement March 1-3, 1993</a><ul id="toc_lst_NBK15127_A11799" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A11799"><a href="/books/n/hsnihcdc/A11796/#A11799" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11805"><a href="/books/n/hsnihcdc/A11796/#A11805" class="toc-item">What Are the Advantages of Early Identification of Hearing Impairment and the Consequences of Late Identification of Hearing Impairment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11806"><a href="/books/n/hsnihcdc/A11796/#A11806" class="toc-item">Which Children (Birth Through 5 Years) Should Be Screened for Hearing Impairment and When?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11807"><a href="/books/n/hsnihcdc/A11796/#A11807" class="toc-item">What Are the Advantages and Disadvantages of Current Screening Methods?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11813"><a href="/books/n/hsnihcdc/A11796/#A11813" class="toc-item">What Is the Preferred Model for Hearing Screening and Followup?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11814"><a href="/books/n/hsnihcdc/A11796/#A11814" class="toc-item">What Are the Important Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11829"><a href="/books/n/hsnihcdc/A11796/#A11829" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11839"><a href="/books/n/hsnihcdc/A11796/#A11839" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11912"><a href="/books/n/hsnihcdc/A11796/#A11912" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11967"><a href="/books/n/hsnihcdc/A11796/#A11967" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12057"><a href="/books/n/hsnihcdc/A11796/#A12057" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A12070"><a href="/books/n/hsnihcdc/A11796/#A12070" class="toc-item">Supplemental Information for NIH Consensus Statement on Early Identification of Hearing Impairment in Infants and Young Children</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A11491"><a href="/books/n/hsnihcdc/A11491/" class="toc-item">91. Impotence: National Institutes of Health Consensus Development Conference Statement December 7-9, 1992</a><ul id="toc_lst_NBK15127_A11494" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A11494"><a href="/books/n/hsnihcdc/A11491/#A11494" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11495"><a href="/books/n/hsnihcdc/A11491/#A11495" class="toc-item">What Are the Prevalence and Clinical, Psychological, and Social Impact of Impotence (cultural, Geographical, National, Ethnic, Racial, Male/Female Perceptions and Influences)?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11498"><a href="/books/n/hsnihcdc/A11491/#A11498" class="toc-item">What Are the Risk Factors Contributing to Impotence? Can These Be Utilized in Preventing Development of Impotence?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11503"><a href="/books/n/hsnihcdc/A11491/#A11503" class="toc-item">What Diagnostic Information Should Be Obtained in Assessment of the Impotent Patient? What Criteria Should Be Employed To Determine Which Tests Are Indicated for a Particular Patient?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11504"><a href="/books/n/hsnihcdc/A11491/#A11504" class="toc-item">What Are the Efficacies and Risks of Behavioral, Pharmacological, Surgical, and Other Treatments for Impotence? What Sequences and/or Combination of These Interventions Are Appropriate? What Management Techniques Are Appropriate When Treatment Is Not Effective or Indicated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11517"><a href="/books/n/hsnihcdc/A11491/#A11517" class="toc-item">What Strategies Are Effective in Improving Public and Professional Knowledge About Impotence?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11528"><a href="/books/n/hsnihcdc/A11491/#A11528" class="toc-item">What Are the Needs for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11544"><a href="/books/n/hsnihcdc/A11491/#A11544" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11556"><a href="/books/n/hsnihcdc/A11491/#A11556" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11629"><a href="/books/n/hsnihcdc/A11491/#A11629" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11678"><a href="/books/n/hsnihcdc/A11491/#A11678" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11782"><a href="/books/n/hsnihcdc/A11491/#A11782" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11795"><a href="/books/n/hsnihcdc/A11491/#A11795" class="toc-item">Supplemental Information for NIH Consensus Statement on Impotence</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A11132"><a href="/books/n/hsnihcdc/A11132/" class="toc-item">90. Gallstones and Laparoscopic Cholecystectomy: National Institutes of Health Consensus Development Conference Statement September 14-16, 1992</a><ul id="toc_lst_NBK15127_A11135" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A11135"><a href="/books/n/hsnihcdc/A11132/#A11135" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11136"><a href="/books/n/hsnihcdc/A11132/#A11136" class="toc-item">Which Patients With Gallstones Should Be Treated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11139"><a href="/books/n/hsnihcdc/A11132/#A11139" class="toc-item">Which Patients With Gallstones Should Be Treated With Laparoscopic Cholecystectomy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11140"><a href="/books/n/hsnihcdc/A11132/#A11140" class="toc-item">What Are the Alternative Medical and Surgical Treatments of Gallstone Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11147"><a href="/books/n/hsnihcdc/A11132/#A11147" class="toc-item">What Are the Results of Laparoscopic Cholecystectomy Compared With Open Cholecystectomy and Other Available Treatments?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11153"><a href="/books/n/hsnihcdc/A11132/#A11153" class="toc-item">How Should Bile Duct Stones Be Detected and Treated When Laparoscopic Cholecystectomy Is or Is Not Contemplated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11161"><a href="/books/n/hsnihcdc/A11132/#A11161" class="toc-item">What Are the Future Directions for Research in the Prevention and Management of Gallstone Disease, and in Laparoscopic Surgery?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11165"><a href="/books/n/hsnihcdc/A11132/#A11165" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11182"><a href="/books/n/hsnihcdc/A11132/#A11182" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11244"><a href="/books/n/hsnihcdc/A11132/#A11244" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11385"><a href="/books/n/hsnihcdc/A11132/#A11385" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11473"><a href="/books/n/hsnihcdc/A11132/#A11473" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11480"><a href="/books/n/hsnihcdc/A11132/#A11480" class="toc-item">Outcomes of Treatment Modalities for Gallbladder (GB) Stones</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A10747"><a href="/books/n/hsnihcdc/A10747/" class="toc-item">89. Triglyceride, High Density Lipoprotein, and Coronary Heart Disease: National Institutes of Health Consensus Development Conference Statement February 26-28, 1992</a><ul id="toc_lst_NBK15127_A10750" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A10750"><a href="/books/n/hsnihcdc/A10747/#A10750" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10757"><a href="/books/n/hsnihcdc/A10747/#A10757" class="toc-item">Is the Relationship of High Triglyceride and/or Low HDL Levels With Coronary Heart Disease Causal?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10760"><a href="/books/n/hsnihcdc/A10747/#A10760" class="toc-item">Will Reduction of High Triglyceride and/or Elevation of HDL Cholesterol Help Prevent Coronary Heart Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10761"><a href="/books/n/hsnihcdc/A10747/#A10761" class="toc-item">Under What Circumstances Should Triglyceride and HDL Be Measured?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10769"><a href="/books/n/hsnihcdc/A10747/#A10769" class="toc-item">What Can Be Accomplished by Dietary, Drug, and Other Hygienic Treatments?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10778"><a href="/books/n/hsnihcdc/A10747/#A10778" class="toc-item">Under What Circumstances Should Active Intervention To Lower Triglyceride and/or Raise HDL Cholesterol Be Considered in High-Risk Individuals and the General Population?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10782"><a href="/books/n/hsnihcdc/A10747/#A10782" class="toc-item">What Are the Significant Questions for Continuing Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10793"><a href="/books/n/hsnihcdc/A10747/#A10793" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10794"><a href="/books/n/hsnihcdc/A10747/#A10794" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10861"><a href="/books/n/hsnihcdc/A10747/#A10861" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11023"><a href="/books/n/hsnihcdc/A10747/#A11023" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11126"><a href="/books/n/hsnihcdc/A10747/#A11126" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A11131"><a href="/books/n/hsnihcdc/A10747/#A11131" class="toc-item">Supplemental Information for NIH Consensus Statement on Triglyceride, High Density Lipoprotein, and Coronary Heart Disease</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A10336"><a href="/books/n/hsnihcdc/A10336/" class="toc-item">88. Diagnosis and Treatment of Early Melanoma: National Institutes of Health Consensus Development Conference Statement January 27-29, 1992</a><ul id="toc_lst_NBK15127_A10339" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A10339"><a href="/books/n/hsnihcdc/A10336/#A10339" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10346"><a href="/books/n/hsnihcdc/A10336/#A10346" class="toc-item">What Are the Clinical and Histological Characteristics of Early Melanoma?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10372"><a href="/books/n/hsnihcdc/A10336/#A10372" class="toc-item">What Is the Appropriate Management of Patients With Early Melanoma Regarding Its Diagnosis and Treatment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10376"><a href="/books/n/hsnihcdc/A10336/#A10376" class="toc-item">After Treatment of Early Melanoma, Should Patients and Family Members Be Followed: Why and How?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10382"><a href="/books/n/hsnihcdc/A10336/#A10382" class="toc-item">Do Dysplastic Nevi Exist and What Is Their Significance?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10389"><a href="/books/n/hsnihcdc/A10336/#A10389" class="toc-item">What Is the Role of Education and Screening in Preventing Melanoma Morbidity and Mortality?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10393"><a href="/books/n/hsnihcdc/A10336/#A10393" class="toc-item">What Are the Future Directions for Research, Including Primary Prevention?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10422"><a href="/books/n/hsnihcdc/A10336/#A10422" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10434"><a href="/books/n/hsnihcdc/A10336/#A10434" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10503"><a href="/books/n/hsnihcdc/A10336/#A10503" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10654"><a href="/books/n/hsnihcdc/A10336/#A10654" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10740"><a href="/books/n/hsnihcdc/A10336/#A10740" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A55220"><a href="/books/n/hsnihcdc/A55220/" class="toc-item">87. Acoustic Neuroma: National Institutes of Health Consensus Development Conference Statement, December 11-13, 1991</a><ul id="toc_lst_NBK15127_A55222" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A55222"><a href="/books/n/hsnihcdc/A55220/#A55222" class="toc-item">Abstract</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55223"><a href="/books/n/hsnihcdc/A55220/#A55223" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55240"><a href="/books/n/hsnihcdc/A55220/#A55240" class="toc-item">What Are Acoustic Neuromas and How Should They Be Classified?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55241"><a href="/books/n/hsnihcdc/A55220/#A55241" class="toc-item">In Whom Should Acoustic Neuroma Be Suspected and Evaluated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55251"><a href="/books/n/hsnihcdc/A55220/#A55251" class="toc-item">What Are the Treatment Options for Those With Acoustic Neuroma?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55252"><a href="/books/n/hsnihcdc/A55220/#A55252" class="toc-item">What Are Possible Adverse Consequences of Treatment and What Are the Management
|
|
Options for Each?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55253"><a href="/books/n/hsnihcdc/A55220/#A55253" class="toc-item">What Are Appropriate Areas for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55254"><a href="/books/n/hsnihcdc/A55220/#A55254" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55271"><a href="/books/n/hsnihcdc/A55220/#A55271" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55342"><a href="/books/n/hsnihcdc/A55220/#A55342" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55538"><a href="/books/n/hsnihcdc/A55220/#A55538" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55623"><a href="/books/n/hsnihcdc/A55220/#A55623" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A9981"><a href="/books/n/hsnihcdc/A9981/" class="toc-item">86. Diagnosis and Treatment of Depression in Late Life: National Institutes of Health Consensus Development Conference Statement November 4-6, 1991</a><ul id="toc_lst_NBK15127_A9984" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A9984"><a href="/books/n/hsnihcdc/A9981/#A9984" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9991"><a href="/books/n/hsnihcdc/A9981/#A9991" class="toc-item">Question 1: How Does Depression in Late Life Differ From Depression Earlier in Life? What Are the Sources of Heterogeneity Within Late Life Depression?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9992"><a href="/books/n/hsnihcdc/A9981/#A9992" class="toc-item">Question 2: How Prevalent is Depression in the Elderly and What Are Its Risk Factors?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9993"><a href="/books/n/hsnihcdc/A9981/#A9993" class="toc-item">Question 3: What Constitutes Safe and Effective Treatment for Late Life Depression? What Are the Indications and Contraindications for Specific Treatments?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9999"><a href="/books/n/hsnihcdc/A9981/#A9999" class="toc-item">Question 4: What Are the Patterns of Health Services Use for Late Life Depression? What Are the Obstacles To Deliver Adequate Treatment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10004"><a href="/books/n/hsnihcdc/A9981/#A10004" class="toc-item">Question 5: What Are the Benefits of Recognizing and Adequately Treating Depression in Late Life? What Are the Consequences of Unrecognized or Inadequately Treated Depression in Late Life?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10009"><a href="/books/n/hsnihcdc/A9981/#A10009" class="toc-item">Question 6: What Are the Most Promising Questions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10022"><a href="/books/n/hsnihcdc/A9981/#A10022" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10023"><a href="/books/n/hsnihcdc/A9981/#A10023" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10097"><a href="/books/n/hsnihcdc/A9981/#A10097" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10234"><a href="/books/n/hsnihcdc/A9981/#A10234" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10325"><a href="/books/n/hsnihcdc/A9981/#A10325" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A10334"><a href="/books/n/hsnihcdc/A9981/#A10334" class="toc-item">Supplemental Information for NIH Consensus Statement on Diagnosis and Treatment of Depression in Late Life</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A9608"><a href="/books/n/hsnihcdc/A9608/" class="toc-item">85. Treatment of Panic Disorder: National Institutes of Health Consensus Development Conference Statement September 25-27, 1991</a><ul id="toc_lst_NBK15127_A9610" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A9610"><a href="/books/n/hsnihcdc/A9608/#A9610" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9616"><a href="/books/n/hsnihcdc/A9608/#A9616" class="toc-item">What Are the Epidemiology, Natural History, and Course of Panic Disorder With and Without Agoraphobia? How Is It Diagnosed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9634"><a href="/books/n/hsnihcdc/A9608/#A9634" class="toc-item">What Are the Current Treatments? What Are the Short-Term and Long-Term Effects of Acute and Extended Treatment of This Disorder?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9635"><a href="/books/n/hsnihcdc/A9608/#A9635" class="toc-item">What Are the Short-Term and Long-Term Adverse Effects of These Treatments? How Should They Be Managed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9639"><a href="/books/n/hsnihcdc/A9608/#A9639" class="toc-item">What Are Considerations for Treatment Planning?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9644"><a href="/books/n/hsnihcdc/A9608/#A9644" class="toc-item">What Are the Significant Questions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9650"><a href="/books/n/hsnihcdc/A9608/#A9650" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9660"><a href="/books/n/hsnihcdc/A9608/#A9660" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9733"><a href="/books/n/hsnihcdc/A9608/#A9733" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9859"><a href="/books/n/hsnihcdc/A9608/#A9859" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9976"><a href="/books/n/hsnihcdc/A9608/#A9976" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A9282"><a href="/books/n/hsnihcdc/A9282/" class="toc-item">84. Gastrointestinal Surgery for Severe Obesity: National Institutes of Health Consensus Development Conference Statement March 25-27, 1991</a><ul id="toc_lst_NBK15127_A9285" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A9285"><a href="/books/n/hsnihcdc/A9282/#A9285" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9286"><a href="/books/n/hsnihcdc/A9282/#A9286" class="toc-item">What Are the Nonsurgical Treatment Options for Severe Obesity and Their
|
|
Consequences?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9287"><a href="/books/n/hsnihcdc/A9282/#A9287" class="toc-item">What Are the Surgical Treatments and Criteria for Selection?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9289"><a href="/books/n/hsnihcdc/A9282/#A9289" class="toc-item">What Are the Efficacy and Risks of Surgical Treatments for Obesity?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9295"><a href="/books/n/hsnihcdc/A9282/#A9295" class="toc-item">What Specific Recommendations Can Be Made for the Treatment of Severe
|
|
Obesity?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9296"><a href="/books/n/hsnihcdc/A9282/#A9296" class="toc-item">What Are the Future Directions for Basic Science, Clinical Research, and
|
|
Epidemiological Evaluation of Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9313"><a href="/books/n/hsnihcdc/A9282/#A9313" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9384"><a href="/books/n/hsnihcdc/A9282/#A9384" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9511"><a href="/books/n/hsnihcdc/A9282/#A9511" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9603"><a href="/books/n/hsnihcdc/A9282/#A9603" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A8849"><a href="/books/n/hsnihcdc/A8849/" class="toc-item">83. Clinical Use of Botulinum Toxin: National Institutes of Health Consensus Development Conference Statement November 12-14, 1990</a><ul id="toc_lst_NBK15127_A8852" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A8852"><a href="/books/n/hsnihcdc/A8849/#A8852" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8858"><a href="/books/n/hsnihcdc/A8849/#A8858" class="toc-item">What Are the Mechanisms of Action of Botulinum Toxin?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8859"><a href="/books/n/hsnihcdc/A8849/#A8859" class="toc-item">What Are the Indications and Contraindications for the Use of Botulinum Toxin Treatment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8861"><a href="/books/n/hsnihcdc/A8849/#A8861" class="toc-item">Ophthalmic Disorders</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8864"><a href="/books/n/hsnihcdc/A8849/#A8864" class="toc-item">Neurological Disorders</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8871"><a href="/books/n/hsnihcdc/A8849/#A8871" class="toc-item">Voice and Speech Disorders</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8876"><a href="/books/n/hsnihcdc/A8849/#A8876" class="toc-item">How Should It Be Handled To Assure Safe and Effective Use?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8877"><a href="/books/n/hsnihcdc/A8849/#A8877" class="toc-item">What Are Its Side Effects and Complications?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8882"><a href="/books/n/hsnihcdc/A8849/#A8882" class="toc-item">What Further Research on Botulinum Toxin Is Needed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8911"><a href="/books/n/hsnihcdc/A8849/#A8911" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8922"><a href="/books/n/hsnihcdc/A8849/#A8922" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8994"><a href="/books/n/hsnihcdc/A8849/#A8994" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9196"><a href="/books/n/hsnihcdc/A8849/#A9196" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A9269"><a href="/books/n/hsnihcdc/A8849/#A9269" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A8488"><a href="/books/n/hsnihcdc/A8488/" class="toc-item">82. Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism: National Institutes of Health Consensus Development Conference Statement October 29-31, 1990</a><ul id="toc_lst_NBK15127_A8491" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A8491"><a href="/books/n/hsnihcdc/A8488/#A8491" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8498"><a href="/books/n/hsnihcdc/A8488/#A8498" class="toc-item">What is the Most Accurate, Cost-Effective Method of Diagnosing Hyperparathyroidism?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8499"><a href="/books/n/hsnihcdc/A8488/#A8499" class="toc-item">Are There Patients With Asymptomatic Hyperparathyroidism Who Can Safely Be Followed? Should They Be?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8512"><a href="/books/n/hsnihcdc/A8488/#A8512" class="toc-item">If Not Operated on, How Should Asymptomatic Patients Be Monitored and Managed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8521"><a href="/books/n/hsnihcdc/A8488/#A8521" class="toc-item">What Are the Indications for Surgery in Patients With Asymptomatic Hyperparathyroidism?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8529"><a href="/books/n/hsnihcdc/A8488/#A8529" class="toc-item">What Is the Role of Gland Localization Technology in Management of Patients With Hyperparathyroidism?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8530"><a href="/books/n/hsnihcdc/A8488/#A8530" class="toc-item">What Research Should Be Done To Clarify Issues in Diagnosis and Management of Hyperparathyroidism?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8531"><a href="/books/n/hsnihcdc/A8488/#A8531" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8539"><a href="/books/n/hsnihcdc/A8488/#A8539" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8617"><a href="/books/n/hsnihcdc/A8488/#A8617" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8760"><a href="/books/n/hsnihcdc/A8488/#A8760" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8842"><a href="/books/n/hsnihcdc/A8488/#A8842" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A8040"><a href="/books/n/hsnihcdc/A8040/" class="toc-item">81. Treatment of Early-Stage Breast Cancer: National Institutes of Health Consensus Development Conference Statement June 18-21, 1990</a><ul id="toc_lst_NBK15127_A8043" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A8043"><a href="/books/n/hsnihcdc/A8040/#A8043" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8049"><a href="/books/n/hsnihcdc/A8040/#A8049" class="toc-item">What Are the Roles of Mastectomy Versus Breast Conservation in the Treatment of Early-Stage Breast Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8058"><a href="/books/n/hsnihcdc/A8040/#A8058" class="toc-item">What Are the Optimal Techniques for Breast Conservation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8071"><a href="/books/n/hsnihcdc/A8040/#A8071" class="toc-item">What Is the Role of Adjuvant Therapy for Patients With Node Negative Breast Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8078"><a href="/books/n/hsnihcdc/A8040/#A8078" class="toc-item">How Should Prognostic Factors Be Used in the Management of Node Negative Breast Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8090"><a href="/books/n/hsnihcdc/A8040/#A8090" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8114"><a href="/books/n/hsnihcdc/A8040/#A8114" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8124"><a href="/books/n/hsnihcdc/A8040/#A8124" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8202"><a href="/books/n/hsnihcdc/A8040/#A8202" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8399"><a href="/books/n/hsnihcdc/A8040/#A8399" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8467"><a href="/books/n/hsnihcdc/A8040/#A8467" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8474"><a href="/books/n/hsnihcdc/A8040/#A8474" class="toc-item">Supplemental Information for NIH Consensus Statement on Treatment of Early Stage Breast Cancer</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A7621"><a href="/books/n/hsnihcdc/A7621/" class="toc-item">80. Intravenous Immunoglobulin: Prevention and Treatment of Disease: National Institutes of Health Consensus Development Conference Statement May 21-23, 1990</a><ul id="toc_lst_NBK15127_A7624" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A7624"><a href="/books/n/hsnihcdc/A7621/#A7624" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7631"><a href="/books/n/hsnihcdc/A7621/#A7631" class="toc-item">What Are the Data To Support the Efficacy of IVIG in These Circumstances?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7644"><a href="/books/n/hsnihcdc/A7621/#A7644" class="toc-item">What Are the Appropriate Dosage and Treatment Schedules?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7645"><a href="/books/n/hsnihcdc/A7621/#A7645" class="toc-item">What Are the Risks Involved in the Use of IVIG?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7654"><a href="/books/n/hsnihcdc/A7621/#A7654" class="toc-item">What Are the Mechanisms of Action?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7655"><a href="/books/n/hsnihcdc/A7621/#A7655" class="toc-item">Are all IVIG Preparations Equally Efficacious?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7656"><a href="/books/n/hsnihcdc/A7621/#A7656" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7663"><a href="/books/n/hsnihcdc/A7621/#A7663" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7673"><a href="/books/n/hsnihcdc/A7621/#A7673" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7751"><a href="/books/n/hsnihcdc/A7621/#A7751" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7908"><a href="/books/n/hsnihcdc/A7621/#A7908" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8016"><a href="/books/n/hsnihcdc/A7621/#A8016" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A8038"><a href="/books/n/hsnihcdc/A7621/#A8038" class="toc-item">Supplemental Information for NIH Consensus Statement on Intravenous Immunoglobulin: Prevention and Treatment of Disease</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A7304"><a href="/books/n/hsnihcdc/A7304/" class="toc-item">79. Adjuvant Therapy for Patients With Colon and Rectum Cancer: National Institutes of Health Consensus Development Conference Statement April 16-18, 1990</a><ul id="toc_lst_NBK15127_A7307" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A7307"><a href="/books/n/hsnihcdc/A7304/#A7307" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7317"><a href="/books/n/hsnihcdc/A7304/#A7317" class="toc-item">Who Is at Risk for Recurrence After Colon and Rectal Cancer Resection?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7318"><a href="/books/n/hsnihcdc/A7304/#A7318" class="toc-item">Is There Effective Adjuvant Therapy for Patients With Colon Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7319"><a href="/books/n/hsnihcdc/A7304/#A7319" class="toc-item">Is There Effective Adjuvant Therapy for Patients With Rectal Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7320"><a href="/books/n/hsnihcdc/A7304/#A7320" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7321"><a href="/books/n/hsnihcdc/A7304/#A7321" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7348"><a href="/books/n/hsnihcdc/A7304/#A7348" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7414"><a href="/books/n/hsnihcdc/A7304/#A7414" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7530"><a href="/books/n/hsnihcdc/A7304/#A7530" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7607"><a href="/books/n/hsnihcdc/A7304/#A7607" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7614"><a href="/books/n/hsnihcdc/A7304/#A7614" class="toc-item">Supplemental Information for NIH Consensus Statement on Adjuvant Therapy for Patients With Colorectal Cancer</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7618"><a href="/books/n/hsnihcdc/A7304/#A7618" class="toc-item">Tables</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A6897"><a href="/books/n/hsnihcdc/A6897/" class="toc-item">78. The Treatment of Sleep Disorders of Older People: National Institutes of Health Consensus Development Conference Statement March 26-28, 1990</a><ul id="toc_lst_NBK15127_A6900" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A6900"><a href="/books/n/hsnihcdc/A6897/#A6900" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6907"><a href="/books/n/hsnihcdc/A6897/#A6907" class="toc-item">What Are the Changes in Sleep and Wakefulness as Functions of Aging and of Diseases of Older People? What Are the Diagnostic Criteria That Establish Clinical Abnormalities? Which Are Clinically and Epidemiologically Important?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6908"><a href="/books/n/hsnihcdc/A6897/#A6908" class="toc-item">What Are the Indications for a Diagnostic Evaluation? What Sequence of Assessment Methods Should Be Used To Determine if the Diagnostic Criteria Are Met?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6909"><a href="/books/n/hsnihcdc/A6897/#A6909" class="toc-item">What Are the Indications for the Treatment of Sleep Disorders?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6917"><a href="/books/n/hsnihcdc/A6897/#A6917" class="toc-item">What Are the Common Medical Practices and Lay Treatment Practices and Their Health Implications?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6920"><a href="/books/n/hsnihcdc/A6897/#A6920" class="toc-item">What Should the Medical Profession and General Public Know About Good Sleep Hygiene and Treatment of Sleep Disorders, and What Should Be Done To Increase awareness?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6921"><a href="/books/n/hsnihcdc/A6897/#A6921" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6922"><a href="/books/n/hsnihcdc/A6897/#A6922" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6938"><a href="/books/n/hsnihcdc/A6897/#A6938" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7012"><a href="/books/n/hsnihcdc/A6897/#A7012" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7185"><a href="/books/n/hsnihcdc/A6897/#A7185" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A7288"><a href="/books/n/hsnihcdc/A6897/#A7288" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A6520"><a href="/books/n/hsnihcdc/A6520/" class="toc-item">77. Surgery for Epilepsy: National Institutes of Health Consensus Development Conference Statement March 19-21, 1990</a><ul id="toc_lst_NBK15127_A6523" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A6523"><a href="/books/n/hsnihcdc/A6520/#A6523" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6529"><a href="/books/n/hsnihcdc/A6520/#A6529" class="toc-item">How Should Patients Be Selected?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6535"><a href="/books/n/hsnihcdc/A6520/#A6535" class="toc-item">What Evaluation Is Necessary To Localize Epileptic Foci?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6540"><a href="/books/n/hsnihcdc/A6520/#A6540" class="toc-item">What Procedures Are Appropriate for Specific Epilepsies?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6544"><a href="/books/n/hsnihcdc/A6520/#A6544" class="toc-item">How Should Outcome Be Assessed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6545"><a href="/books/n/hsnihcdc/A6520/#A6545" class="toc-item">Directions for Future Research—Should a Controlled Trial Be Done? If So, for What Seizure Types?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6553"><a href="/books/n/hsnihcdc/A6520/#A6553" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6560"><a href="/books/n/hsnihcdc/A6520/#A6560" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6634"><a href="/books/n/hsnihcdc/A6520/#A6634" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6831"><a href="/books/n/hsnihcdc/A6520/#A6831" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6892"><a href="/books/n/hsnihcdc/A6520/#A6892" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A6152"><a href="/books/n/hsnihcdc/A6152/" class="toc-item">76. Noise and Hearing Loss: National Institutes of Health Consensus Development Conference Statement January 22-24, 1990</a><ul id="toc_lst_NBK15127_A6155" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A6155"><a href="/books/n/hsnihcdc/A6152/#A6155" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6166"><a href="/books/n/hsnihcdc/A6152/#A6166" class="toc-item">What is Noise-Induced Hearing Loss?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6170"><a href="/books/n/hsnihcdc/A6152/#A6170" class="toc-item">What Sounds Can Damage Hearing?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6171"><a href="/books/n/hsnihcdc/A6152/#A6171" class="toc-item">What Factors, Including Age, Determine an Individual's Susceptibility to Noise-Induced Hearing Loss?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6177"><a href="/books/n/hsnihcdc/A6152/#A6177" class="toc-item">What Can Be Done To Prevent Noise-Induced Hearing Loss?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6182"><a href="/books/n/hsnihcdc/A6152/#A6182" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6195"><a href="/books/n/hsnihcdc/A6152/#A6195" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6206"><a href="/books/n/hsnihcdc/A6152/#A6206" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6282"><a href="/books/n/hsnihcdc/A6152/#A6282" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6417"><a href="/books/n/hsnihcdc/A6152/#A6417" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6509"><a href="/books/n/hsnihcdc/A6152/#A6509" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A54861"><a href="/books/n/hsnihcdc/A54861/" class="toc-item">75. Treatment of Destructive Behaviors in Persons With Developmental Disabilities: National Institutes of Health Consensus Development Conference Statement, September 11-13, 1989</a><ul id="toc_lst_NBK15127_A54863" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A54863"><a href="/books/n/hsnihcdc/A54861/#A54863" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54882"><a href="/books/n/hsnihcdc/A54861/#A54882" class="toc-item">What Are the Nature, Extent, and Consequences of Destructive Behaviors in Persons With Developmental Disabilities?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54883"><a href="/books/n/hsnihcdc/A54861/#A54883" class="toc-item">What Are the Approaches to Prevent, Treat, and Manage These Behaviors?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54899"><a href="/books/n/hsnihcdc/A54861/#A54899" class="toc-item">What Is the Evidence That These Approaches, Alone or in Combination, Eliminate or Reduce Destructive Behaviors?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54905"><a href="/books/n/hsnihcdc/A54861/#A54905" class="toc-item">What Are the Risks and Benefits Associated With the Use of These Approaches for the Individual, Family, and Community?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54906"><a href="/books/n/hsnihcdc/A54861/#A54906" class="toc-item">Based on the Answers to the Above Questions and Taking Into Account the Behavior; the Diagnosis and Functional Level of the Individual; Possible Effects on the Individual, Family, and Community; the Treatment Setting; and Other Factors, What Recommendations Can Be Made at Present Regarding the Use of the Different Approaches?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54907"><a href="/books/n/hsnihcdc/A54861/#A54907" class="toc-item">What Research Is Needed on Approaches for Preventing, Treating, and Managing Destructive Behaviors in Persons With Developmental Disabilities?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54922"><a href="/books/n/hsnihcdc/A54861/#A54922" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54933"><a href="/books/n/hsnihcdc/A54861/#A54933" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55015"><a href="/books/n/hsnihcdc/A54861/#A55015" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55119"><a href="/books/n/hsnihcdc/A54861/#A55119" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A55209"><a href="/books/n/hsnihcdc/A54861/#A55209" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A5818"><a href="/books/n/hsnihcdc/A5818/" class="toc-item">74. Sunlight, Ultraviolet Radiation, and the Skin: National Institutes of Health Consensus Development Conference Statement May 8-10, 1989</a><ul id="toc_lst_NBK15127_A5820" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A5820"><a href="/books/n/hsnihcdc/A5818/#A5820" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5827"><a href="/books/n/hsnihcdc/A5818/#A5827" class="toc-item">What Are the Sources of Ultraviolet Radiation, and Is the Extent of Human Exposure Changing Over Time?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5828"><a href="/books/n/hsnihcdc/A5818/#A5828" class="toc-item">What Are the Effects of Sunlight on the Skin?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5829"><a href="/books/n/hsnihcdc/A5818/#A5829" class="toc-item">What Factors Influence Susceptibility to Ultraviolet Radiation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5830"><a href="/books/n/hsnihcdc/A5818/#A5830" class="toc-item">Can Ultraviolet-Induced Changes Be Prevented? If So, How?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5836"><a href="/books/n/hsnihcdc/A5818/#A5836" class="toc-item">Are Sunlight-Induced Adverse Skin Alterations Treatable And/or Reversible? If So, How?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5837"><a href="/books/n/hsnihcdc/A5818/#A5837" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5850"><a href="/books/n/hsnihcdc/A5818/#A5850" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5857"><a href="/books/n/hsnihcdc/A5818/#A5857" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5936"><a href="/books/n/hsnihcdc/A5818/#A5936" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6063"><a href="/books/n/hsnihcdc/A5818/#A6063" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A6145"><a href="/books/n/hsnihcdc/A5818/#A6145" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A5375"><a href="/books/n/hsnihcdc/A5375/" class="toc-item">73. Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment: National Institutes of Health Consensus Development Conference Statement April 17-19, 1989</a><ul id="toc_lst_NBK15127_A5377" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A5377"><a href="/books/n/hsnihcdc/A5375/#A5377" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5384"><a href="/books/n/hsnihcdc/A5375/#A5384" class="toc-item">Is There a Role for Pretherapy Interventions Affecting the Oral Cavity in Reducing the Incidence of Oral Complications in the Cancer Patient?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5388"><a href="/books/n/hsnihcdc/A5375/#A5388" class="toc-item">Which Pretreatment Strategies Are Optimal To Prevent or Minimize Oral Complications?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5389"><a href="/books/n/hsnihcdc/A5375/#A5389" class="toc-item">What Are the Most Effective Strategies for Management of Acute Oral Complications Occurring During Cancer Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5395"><a href="/books/n/hsnihcdc/A5375/#A5395" class="toc-item">What Are the Indicated Strategies for Management of Chronic Oral Complications Following Cancer Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5400"><a href="/books/n/hsnihcdc/A5375/#A5400" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5422"><a href="/books/n/hsnihcdc/A5375/#A5422" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5435"><a href="/books/n/hsnihcdc/A5375/#A5435" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5512"><a href="/books/n/hsnihcdc/A5375/#A5512" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5715"><a href="/books/n/hsnihcdc/A5375/#A5715" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5801"><a href="/books/n/hsnihcdc/A5375/#A5801" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5817"><a href="/books/n/hsnihcdc/A5375/#A5817" class="toc-item">Supplemental Information for NIH Consensus Statement on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A5051"><a href="/books/n/hsnihcdc/A5051/" class="toc-item">72. Therapeutic Endoscopy and Bleeding Ulcers: National Institutes of Health Consensus Development Conference Statement March 6-8, 1989</a><ul id="toc_lst_NBK15127_A5053" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A5053"><a href="/books/n/hsnihcdc/A5051/#A5053" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5059"><a href="/books/n/hsnihcdc/A5051/#A5059" class="toc-item">Which Bleeding Ulcer Patients Are at Risk for Rebleeding and Thus Emergency Surgery?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5065"><a href="/books/n/hsnihcdc/A5051/#A5065" class="toc-item">How Effective Is Endoscopic Hemostatic Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5076"><a href="/books/n/hsnihcdc/A5051/#A5076" class="toc-item">How Safe Is Endoscopic Hemostatic Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5080"><a href="/books/n/hsnihcdc/A5051/#A5080" class="toc-item">Which Bleeding Ulcer Patients Should Be Treated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5081"><a href="/books/n/hsnihcdc/A5051/#A5081" class="toc-item">What Further Research Is Required?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5088"><a href="/books/n/hsnihcdc/A5051/#A5088" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5099"><a href="/books/n/hsnihcdc/A5051/#A5099" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5192"><a href="/books/n/hsnihcdc/A5051/#A5192" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5288"><a href="/books/n/hsnihcdc/A5051/#A5288" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5368"><a href="/books/n/hsnihcdc/A5051/#A5368" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A4598"><a href="/books/n/hsnihcdc/A4598/" class="toc-item">71. Urinary Incontinence in Adults: National Institutes of Health Consensus Development Conference Statement October 3-5, 1988</a><ul id="toc_lst_NBK15127_A4600" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A4600"><a href="/books/n/hsnihcdc/A4598/#A4600" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4607"><a href="/books/n/hsnihcdc/A4598/#A4607" class="toc-item">What Is the Prevalence and Clinical, Psychological, and Social Impact of Urinary Incontinence Among Persons Living at Home and in Institutions?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4612"><a href="/books/n/hsnihcdc/A4598/#A4612" class="toc-item">What Are the Pathophysiological and Functional Factors Leading to Urinary Incontinence?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4614"><a href="/books/n/hsnihcdc/A4598/#A4614" class="toc-item">What Diagnostic Information Should Be Obtained in Assessment of the Incontinent Patient? What Criteria Should Be Employed To Determine Which Tests Are Indicated for a Particular Patient?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4626"><a href="/books/n/hsnihcdc/A4598/#A4626" class="toc-item">What Are the Efficacies and Limitations of Behavioral, Pharmacological, Surgical, and Other Treatments for Urinary Incontinence? What Sequences and/or combination of These Interventions Are Appropriate? What Management Techniques Are Appropriate When Treatment Is Not Effective or Indicated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4650"><a href="/books/n/hsnihcdc/A4598/#A4650" class="toc-item">What Strategies Are Effective in Improving Public and Professional Knowledge About Urinary Incontinence?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4653"><a href="/books/n/hsnihcdc/A4598/#A4653" class="toc-item">What Are the Needs for Future Research Related to Urinary Incontinence?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4659"><a href="/books/n/hsnihcdc/A4598/#A4659" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4671"><a href="/books/n/hsnihcdc/A4598/#A4671" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4758"><a href="/books/n/hsnihcdc/A4598/#A4758" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4942"><a href="/books/n/hsnihcdc/A4598/#A4942" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5028"><a href="/books/n/hsnihcdc/A4598/#A5028" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A5047"><a href="/books/n/hsnihcdc/A4598/#A5047" class="toc-item">Supplemental Information for NIH Consensus Statement on Urinary Incontinence</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A4279"><a href="/books/n/hsnihcdc/A4279/" class="toc-item">70. Perioperative Red Cell Transfusion: National Institutes of Health Consensus Development Conference Statement June 27-29, 1988</a><ul id="toc_lst_NBK15127_A4281" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A4281"><a href="/books/n/hsnihcdc/A4279/#A4281" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4287"><a href="/books/n/hsnihcdc/A4279/#A4287" class="toc-item">What Should the Criteria Be for Perioperative Red Blood Cell Transfusion?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4288"><a href="/books/n/hsnihcdc/A4279/#A4288" class="toc-item">What Is the Morbidity of Anemia in the Perioperative Period?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4289"><a href="/books/n/hsnihcdc/A4279/#A4289" class="toc-item">What Are the Risks of Red Cell Transfusion—Both Immediate and Long Term?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4296"><a href="/books/n/hsnihcdc/A4279/#A4296" class="toc-item">What Are the Alternatives to Red Cell Transfusion?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4303"><a href="/books/n/hsnihcdc/A4279/#A4303" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4314"><a href="/books/n/hsnihcdc/A4279/#A4314" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4320"><a href="/books/n/hsnihcdc/A4279/#A4320" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4394"><a href="/books/n/hsnihcdc/A4279/#A4394" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4523"><a href="/books/n/hsnihcdc/A4279/#A4523" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4585"><a href="/books/n/hsnihcdc/A4279/#A4585" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4597"><a href="/books/n/hsnihcdc/A4279/#A4597" class="toc-item">Supplemental Information for NIH Consensus Statement on Perioperative Red Cell Transfusion</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A54499"><a href="/books/n/hsnihcdc/A54499/" class="toc-item">69. Dental Implants: National Institutes of Health Consensus Development Conference Statement, June 13-15, 1988</a><ul id="toc_lst_NBK15127_A54501" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A54501"><a href="/books/n/hsnihcdc/A54499/#A54501" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54507"><a href="/books/n/hsnihcdc/A54499/#A54507" class="toc-item">What Is the Evidence That Implants Are Effective for the Long Term?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54517"><a href="/books/n/hsnihcdc/A54499/#A54517" class="toc-item">What Are the Indications and Contraindications of Various Types of Dental Implants?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54569"><a href="/books/n/hsnihcdc/A54499/#A54569" class="toc-item">What Are the Requirements for Surgical, Restorative, and Periodontal Management of Patients With Dental Implants?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54570"><a href="/books/n/hsnihcdc/A54499/#A54570" class="toc-item">What Are the Health Risks of Dental Implants?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54571"><a href="/books/n/hsnihcdc/A54499/#A54571" class="toc-item">What Are the Future Directions for Research on Materials and Designs of Dental Implants and on Clinical Management?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54575"><a href="/books/n/hsnihcdc/A54499/#A54575" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54576"><a href="/books/n/hsnihcdc/A54499/#A54576" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54637"><a href="/books/n/hsnihcdc/A54499/#A54637" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54773"><a href="/books/n/hsnihcdc/A54499/#A54773" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54852"><a href="/books/n/hsnihcdc/A54499/#A54852" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A54144"><a href="/books/n/hsnihcdc/A54144/" class="toc-item">68. Cochlear Implants: National Institutes of Health Consensus Development Conference Statement, May 2-4, 1988</a><ul id="toc_lst_NBK15127_A54146" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A54146"><a href="/books/n/hsnihcdc/A54144/#A54146" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54153"><a href="/books/n/hsnihcdc/A54144/#A54153" class="toc-item">Who Is a Suitable Candidate for a Cochlear Implant?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54160"><a href="/books/n/hsnihcdc/A54144/#A54160" class="toc-item">What Are the Advantages and Disadvantages of the Different Types of Cochlear Implants?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54161"><a href="/books/n/hsnihcdc/A54144/#A54161" class="toc-item">How Effective Are Cochlear Implants?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54167"><a href="/books/n/hsnihcdc/A54144/#A54167" class="toc-item">What Are the Risks and Limitations of Cochlear Implantation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54171"><a href="/books/n/hsnihcdc/A54144/#A54171" class="toc-item">What Are the Important Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54172"><a href="/books/n/hsnihcdc/A54144/#A54172" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54173"><a href="/books/n/hsnihcdc/A54144/#A54173" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54249"><a href="/books/n/hsnihcdc/A54144/#A54249" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54394"><a href="/books/n/hsnihcdc/A54144/#A54394" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54488"><a href="/books/n/hsnihcdc/A54144/#A54488" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A53833"><a href="/books/n/hsnihcdc/A53833/" class="toc-item">67. Prevention and Treatment of Kidney Stones: National Institutes of Health Consensus Development Conference Statement, March 28-30, 1988</a><ul id="toc_lst_NBK15127_A53835" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A53835"><a href="/books/n/hsnihcdc/A53833/#A53835" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53840"><a href="/books/n/hsnihcdc/A53833/#A53840" class="toc-item">What Are the Methods of Medical Prevention, and How Successful Are They?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53847"><a href="/books/n/hsnihcdc/A53833/#A53847" class="toc-item">What Is the Role of Lithotripsy, and Can It Replace Medical Prevention? </a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53848"><a href="/books/n/hsnihcdc/A53833/#A53848" class="toc-item">What Are Clinical and Laboratory Approaches for the Evaluation of Patients With Stones? </a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53849"><a href="/books/n/hsnihcdc/A53833/#A53849" class="toc-item">What Are the Directions for Future Research? </a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53870"><a href="/books/n/hsnihcdc/A53833/#A53870" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53871"><a href="/books/n/hsnihcdc/A53833/#A53871" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53953"><a href="/books/n/hsnihcdc/A53833/#A53953" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54074"><a href="/books/n/hsnihcdc/A53833/#A54074" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A54137"><a href="/books/n/hsnihcdc/A53833/#A54137" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A53404"><a href="/books/n/hsnihcdc/A53404/" class="toc-item">66. Magnetic Resonance Imaging: National Institutes of Health Consensus Development Conference Statement, October 26-28, 1987</a><ul id="toc_lst_NBK15127_A53406" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A53406"><a href="/books/n/hsnihcdc/A53404/#A53406" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53411"><a href="/books/n/hsnihcdc/A53404/#A53411" class="toc-item">Are There Contraindications to or Risks of MRI?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53412"><a href="/books/n/hsnihcdc/A53404/#A53412" class="toc-item">What Are the Technological Advantages and Limitations (Disadvantages) of MRI?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53415"><a href="/books/n/hsnihcdc/A53404/#A53415" class="toc-item">What Are the Clinical Indications for MRI, and How Does It Compare to Other Diagnostic Modalities?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53470"><a href="/books/n/hsnihcdc/A53404/#A53470" class="toc-item">What Are the Directions for Future Research in MRI?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53471"><a href="/books/n/hsnihcdc/A53404/#A53471" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53472"><a href="/books/n/hsnihcdc/A53404/#A53472" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53556"><a href="/books/n/hsnihcdc/A53404/#A53556" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53693"><a href="/books/n/hsnihcdc/A53404/#A53693" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53805"><a href="/books/n/hsnihcdc/A53404/#A53805" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A3922"><a href="/books/n/hsnihcdc/A3922/" class="toc-item">65. Geriatric Assessment Methods for Clinical Decision Making: National Institutes of Health Consensus Development Conference Statement October 19-21, 1987</a><ul id="toc_lst_NBK15127_A3924" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A3924"><a href="/books/n/hsnihcdc/A3922/#A3924" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3930"><a href="/books/n/hsnihcdc/A3922/#A3930" class="toc-item">What Are the Goals, Structure, Processes, and Elements of Geriatric Assessment for Clinical Decision Making?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3941"><a href="/books/n/hsnihcdc/A3922/#A3941" class="toc-item">What Are the Comparative Merits of Different Methods in Carrying Out a Geriatric Assessment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3942"><a href="/books/n/hsnihcdc/A3922/#A3942" class="toc-item">What Is the Evidence That a Geriatric Assessment Is Effective? If So, in What Settings, for Whom, and for Which Outcomes?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3943"><a href="/books/n/hsnihcdc/A3922/#A3943" class="toc-item">Insofar as a Geriatric Assessment Is Effective, What Linkages to Clinical Management Systems Are Required?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3944"><a href="/books/n/hsnihcdc/A3922/#A3944" class="toc-item">What Are the Priorities for Future Research in Geriatric Assessment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3954"><a href="/books/n/hsnihcdc/A3922/#A3954" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3955"><a href="/books/n/hsnihcdc/A3922/#A3955" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4048"><a href="/books/n/hsnihcdc/A3922/#A4048" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4178"><a href="/books/n/hsnihcdc/A3922/#A4178" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A4263"><a href="/books/n/hsnihcdc/A3922/#A4263" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A52976"><a href="/books/n/hsnihcdc/A52976/" class="toc-item">64. Neurofibromatosis: National Institutes of Health Consensus Development Conference Statement, July 13-15, 1987</a><ul id="toc_lst_NBK15127_A52978" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A52978"><a href="/books/n/hsnihcdc/A52976/#A52978" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52983"><a href="/books/n/hsnihcdc/A52976/#A52983" class="toc-item">Neurofibromatosis 1</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53013"><a href="/books/n/hsnihcdc/A52976/#A53013" class="toc-item">Neurofibromatosis 2</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53042"><a href="/books/n/hsnihcdc/A52976/#A53042" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53043"><a href="/books/n/hsnihcdc/A52976/#A53043" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53122"><a href="/books/n/hsnihcdc/A52976/#A53122" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53318"><a href="/books/n/hsnihcdc/A52976/#A53318" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A53394"><a href="/books/n/hsnihcdc/A52976/#A53394" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A3526"><a href="/books/n/hsnihcdc/A3526/" class="toc-item">63. Differential Diagnosis of Dementing Diseases: National Institutes of Health Consensus Development Conference StatementJuly 6-8, 1987</a><ul id="toc_lst_NBK15127_A3528" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A3528"><a href="/books/n/hsnihcdc/A3526/#A3528" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3534"><a href="/books/n/hsnihcdc/A3526/#A3534" class="toc-item">What Is Dementia?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3535"><a href="/books/n/hsnihcdc/A3526/#A3535" class="toc-item">What Are the Dementing Diseases, and Which of These Can Be Readily Arrested or Reversed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3546"><a href="/books/n/hsnihcdc/A3526/#A3546" class="toc-item">What Should Be Included in the Initial Evaluation of Dementia?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3547"><a href="/books/n/hsnihcdc/A3526/#A3547" class="toc-item">What Diagnostic Tests Should Be Performed, and When Are These Tests Indicated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3572"><a href="/books/n/hsnihcdc/A3526/#A3572" class="toc-item">What Are the Priorities for Future Research on Diagnosing the Dementias?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3582"><a href="/books/n/hsnihcdc/A3526/#A3582" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3583"><a href="/books/n/hsnihcdc/A3526/#A3583" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3649"><a href="/books/n/hsnihcdc/A3526/#A3649" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3810"><a href="/books/n/hsnihcdc/A3526/#A3810" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3910"><a href="/books/n/hsnihcdc/A3526/#A3910" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A52629"><a href="/books/n/hsnihcdc/A52629/" class="toc-item">62. The Management of Clinically Localized Prostate Cancer: National Institutes of Health Consensus Development Conference Statement, June 15-17, 1987</a><ul id="toc_lst_NBK15127_A52631" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A52631"><a href="/books/n/hsnihcdc/A52629/#A52631" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52637"><a href="/books/n/hsnihcdc/A52629/#A52637" class="toc-item">What Is the Utility of Pathological Assessment and Imaging Techniques in the Staging of Prostate Cancer? When Is Pelvic Node Dissection Necessary?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52638"><a href="/books/n/hsnihcdc/A52629/#A52638" class="toc-item">Who Is the Optimal Candidate for Radical Prostatectomy? What Is the Morbidity of the Procedure, and How Can It Be Minimized With Preservation of Curative Potential?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52639"><a href="/books/n/hsnihcdc/A52629/#A52639" class="toc-item">Who Are the Candidates for Definitive Radiation Therapy? What Methods Are Optimal and What Are the Long-Term Results in Terms of Local Control and Survival? What Is the Morbidity of the Procedures, and How Can It Be Minimized With Preservation of Curative Potential?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52640"><a href="/books/n/hsnihcdc/A52629/#A52640" class="toc-item">Should Definitive Radiation Therapy, Hormone Therapy, and/or Chemotherapy Be Employed as Adjuvant Treatment in High-Risk Patients?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52641"><a href="/books/n/hsnihcdc/A52629/#A52641" class="toc-item">What Directions for Future Research Are Indicated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52658"><a href="/books/n/hsnihcdc/A52629/#A52658" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52664"><a href="/books/n/hsnihcdc/A52629/#A52664" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52744"><a href="/books/n/hsnihcdc/A52629/#A52744" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52892"><a href="/books/n/hsnihcdc/A52629/#A52892" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52968"><a href="/books/n/hsnihcdc/A52629/#A52968" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A3041"><a href="/books/n/hsnihcdc/A3041/" class="toc-item">61. Newborn Screening for Sickle Cell Disease and Other Hemoglobinopathies: National Institutes of Health Consensus Development Conference Statement April 6-8, 1987</a><ul id="toc_lst_NBK15127_A3043" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A3043"><a href="/books/n/hsnihcdc/A3041/#A3043" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3049"><a href="/books/n/hsnihcdc/A3041/#A3049" class="toc-item">Are Programs for Screening the Newborn for Sickle Cell Disease Effective in Decreasing Morbidity and Mortality?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3050"><a href="/books/n/hsnihcdc/A3041/#A3050" class="toc-item">What Are the Techniques of Screening, and What is Their Efficacy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3051"><a href="/books/n/hsnihcdc/A3041/#A3051" class="toc-item">What Are the Major Factors To Be Considered, Including Benefits and Risks, in Conducting Newborn Screening Programs?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3058"><a href="/books/n/hsnihcdc/A3041/#A3058" class="toc-item">What Are the Optimal Followup and Management of Infants Identified With Hemoglobinopathies (Disease and Carriers)?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3075"><a href="/books/n/hsnihcdc/A3041/#A3075" class="toc-item">What Future Research Directions Are Indicated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3076"><a href="/books/n/hsnihcdc/A3041/#A3076" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3083"><a href="/books/n/hsnihcdc/A3041/#A3083" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3168"><a href="/books/n/hsnihcdc/A3041/#A3168" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3425"><a href="/books/n/hsnihcdc/A3041/#A3425" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3511"><a href="/books/n/hsnihcdc/A3041/#A3511" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A2763"><a href="/books/n/hsnihcdc/A2763/" class="toc-item">60. Diet and Exercise in Non-Insulin-Dependent Diabetes Mellitus: National Institutes of Health Consensus Development Conference Statement December 8-10, 1986</a><ul id="toc_lst_NBK15127_A2765" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A2765"><a href="/books/n/hsnihcdc/A2763/#A2765" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2771"><a href="/books/n/hsnihcdc/A2763/#A2771" class="toc-item">What Is the Significance of Excess Body Fat in the Patient With Noninsulin-Dependent Diabetes Mellitus? How Can Weight Reduction Be Achieved and Maintained?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2772"><a href="/books/n/hsnihcdc/A2763/#A2772" class="toc-item">What Are the Appropriate Components of the Dietary Prescription for Patients With Noninsulin-Dependent Diabetes Mellitus?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2781"><a href="/books/n/hsnihcdc/A2763/#A2781" class="toc-item">What Are the Benefits and Risks of Exercise in Patients With Noninsulin-Dependent Diabetes Mellitus? How Should Exercise Be Prescribed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2782"><a href="/books/n/hsnihcdc/A2763/#A2782" class="toc-item">What Is the Evidence That Weight Control, Diet, and/or Exercise Can Prevent Noninsulin-Dependent Diabetes Mellitus?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2783"><a href="/books/n/hsnihcdc/A2763/#A2783" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2805"><a href="/books/n/hsnihcdc/A2763/#A2805" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2806"><a href="/books/n/hsnihcdc/A2763/#A2806" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2864"><a href="/books/n/hsnihcdc/A2763/#A2864" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2968"><a href="/books/n/hsnihcdc/A2763/#A2968" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A3036"><a href="/books/n/hsnihcdc/A2763/#A3036" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A2436"><a href="/books/n/hsnihcdc/A2436/" class="toc-item">59. Platelet Transfusion Therapy: National Institutes of Health Consensus Development Conference Statement October 6-8, 1986</a><ul id="toc_lst_NBK15127_A2438" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A2438"><a href="/books/n/hsnihcdc/A2436/#A2438" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2443"><a href="/books/n/hsnihcdc/A2436/#A2443" class="toc-item">What Are the Appropriate Indications for Platelet Transfusion?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2449"><a href="/books/n/hsnihcdc/A2436/#A2449" class="toc-item">What Products Are Available, and What Are Their Relative Merits?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2455"><a href="/books/n/hsnihcdc/A2436/#A2455" class="toc-item">What Are the Risks Associated With Platelet Transfusion Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2459"><a href="/books/n/hsnihcdc/A2436/#A2459" class="toc-item">What Are the Most Important Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2476"><a href="/books/n/hsnihcdc/A2436/#A2476" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2477"><a href="/books/n/hsnihcdc/A2436/#A2477" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2556"><a href="/books/n/hsnihcdc/A2436/#A2556" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2701"><a href="/books/n/hsnihcdc/A2436/#A2701" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2755"><a href="/books/n/hsnihcdc/A2436/#A2755" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2762"><a href="/books/n/hsnihcdc/A2436/#A2762" class="toc-item">Supplemental Information for NIH Consensus Statement on Platelet Transfusion Therapy</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A2122"><a href="/books/n/hsnihcdc/A2122/" class="toc-item">58. Infantile Apnea and Home Monitoring: National Institutes of Health Consensus Development Conference Statement September 29-October 1, 1986</a><ul id="toc_lst_NBK15127_A2124" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A2124"><a href="/books/n/hsnihcdc/A2122/#A2124" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2131"><a href="/books/n/hsnihcdc/A2122/#A2131" class="toc-item">What Is Known About the Relation of Neonatal and Infant Apnea to Each Other and to Mortality (Especially SIDS) and Morbidity in Infancy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2132"><a href="/books/n/hsnihcdc/A2122/#A2132" class="toc-item">What Are the Efficacy and Safety of Currently Available Home Devices for Detecting Infant Apnea?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2136"><a href="/books/n/hsnihcdc/A2122/#A2136" class="toc-item">What Evidence Exists Regarding the Effectiveness of Home Monitoring in Reducing Infant Mortality (Especially SIDS) and Morbidity?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2145"><a href="/books/n/hsnihcdc/A2122/#A2145" class="toc-item">Based on the Above, What Recommendations Can Be Made at Present Regarding the Circumstances for Use of Home Apnea Monitoring in Infancy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2146"><a href="/books/n/hsnihcdc/A2122/#A2146" class="toc-item">What Further Research Is Needed on Home Apnea Monitoring for Infants?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2178"><a href="/books/n/hsnihcdc/A2122/#A2178" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2179"><a href="/books/n/hsnihcdc/A2122/#A2179" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2247"><a href="/books/n/hsnihcdc/A2122/#A2247" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2333"><a href="/books/n/hsnihcdc/A2122/#A2333" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2420"><a href="/books/n/hsnihcdc/A2122/#A2420" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A52228"><a href="/books/n/hsnihcdc/A52228/" class="toc-item">57. The Impact of Routine HTLV-III Antibody Testing of Blood and Plasma Donors on Public Health: National Institutes of Health Consensus Development Conference Statement, July 7-9, 1986</a><ul id="toc_lst_NBK15127_A52230" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A52230"><a href="/books/n/hsnihcdc/A52228/#A52230" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52238"><a href="/books/n/hsnihcdc/A52228/#A52238" class="toc-item">What Tests Are Currently Being Used? What Are Their Performance Characteristics?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52247"><a href="/books/n/hsnihcdc/A52228/#A52247" class="toc-item">What Constitutes a Positive Test? How Should a Positive HIV-Antibody Test Result Be Interpreted? How Should These Tests Be Used?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52248"><a href="/books/n/hsnihcdc/A52228/#A52248" class="toc-item">How Should Positive Test Results Be Handled?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52258"><a href="/books/n/hsnihcdc/A52228/#A52258" class="toc-item">What Are the Psychosocial Ramifications for Blood Donors of Knowledge of a Positive Test Result?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52259"><a href="/books/n/hsnihcdc/A52228/#A52259" class="toc-item">What Impact Has Testing Had on Transfusion Medicine?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52264"><a href="/books/n/hsnihcdc/A52228/#A52264" class="toc-item">What Research Directions Should Be Pursued?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52265"><a href="/books/n/hsnihcdc/A52228/#A52265" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52266"><a href="/books/n/hsnihcdc/A52228/#A52266" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52341"><a href="/books/n/hsnihcdc/A52228/#A52341" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52521"><a href="/books/n/hsnihcdc/A52228/#A52521" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52607"><a href="/books/n/hsnihcdc/A52228/#A52607" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A1743"><a href="/books/n/hsnihcdc/A1743/" class="toc-item">56. The Utility of Therapeutic Plasmapheresis for Neurological Disorders: National Institutes of Health Consensus Development Conference Statement June 2-4, 1986</a><ul id="toc_lst_NBK15127_A1745" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A1745"><a href="/books/n/hsnihcdc/A1743/#A1745" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1752"><a href="/books/n/hsnihcdc/A1743/#A1752" class="toc-item">Is Therapeutic Plasmapheresis of Benefit for Neurological Diseases? If So, for Which Diseases and Under What Circumstances?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1760"><a href="/books/n/hsnihcdc/A1743/#A1760" class="toc-item">What Are the Risks of Plasmapheresis?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1769"><a href="/books/n/hsnihcdc/A1743/#A1769" class="toc-item">If Effective, What Are the Mechanisms of Action?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1773"><a href="/books/n/hsnihcdc/A1743/#A1773" class="toc-item">Is Efficacy Influenced by Technique?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1774"><a href="/books/n/hsnihcdc/A1743/#A1774" class="toc-item">What Is the Relationship of Plasmapheresis to Other Therapies?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1780"><a href="/books/n/hsnihcdc/A1743/#A1780" class="toc-item">What Insights Has Plasmapheresis Provided To Suggest Relevant Clinical or Basic Research Strategies?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1789"><a href="/books/n/hsnihcdc/A1743/#A1789" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1790"><a href="/books/n/hsnihcdc/A1743/#A1790" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1868"><a href="/books/n/hsnihcdc/A1743/#A1868" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2013"><a href="/books/n/hsnihcdc/A1743/#A2013" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2108"><a href="/books/n/hsnihcdc/A1743/#A2108" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A2119"><a href="/books/n/hsnihcdc/A1743/#A2119" class="toc-item">Supplemental Information for NIH Consensus Statement on the Utility of Therapeutic Plasmapheresis for Neurological Disorders</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A51921"><a href="/books/n/hsnihcdc/A51921/" class="toc-item">55. The Integrated Approach to the Management of Pain: National Institutes of Health Consensus Development Conference Statement, May 19-21, 1986</a><ul id="toc_lst_NBK15127_A51923" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A51923"><a href="/books/n/hsnihcdc/A51921/#A51923" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51929"><a href="/books/n/hsnihcdc/A51921/#A51929" class="toc-item">How Should Pain Be Assessed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51933"><a href="/books/n/hsnihcdc/A51921/#A51933" class="toc-item">How Should Pharmacological Agents Be Used in an Integrated Approach to Pain Management?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51940"><a href="/books/n/hsnihcdc/A51921/#A51940" class="toc-item">How Should Nonpharmacological Interventions Be Used in an Integrated Approach to Pain Management?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51941"><a href="/books/n/hsnihcdc/A51921/#A51941" class="toc-item">What Is the Role of the Nurse in the Integrated Approach to Pain Management?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51948"><a href="/books/n/hsnihcdc/A51921/#A51948" class="toc-item">What Are the Directions for Future Research in Pain Management?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51958"><a href="/books/n/hsnihcdc/A51921/#A51958" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51959"><a href="/books/n/hsnihcdc/A51921/#A51959" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52038"><a href="/books/n/hsnihcdc/A51921/#A52038" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52150"><a href="/books/n/hsnihcdc/A51921/#A52150" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52214"><a href="/books/n/hsnihcdc/A51921/#A52214" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A52225"><a href="/books/n/hsnihcdc/A51921/#A52225" class="toc-item">Supplemental Information for NIH Consensus Statement on Integrated Approach to the Management of Pain</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A51600"><a href="/books/n/hsnihcdc/A51600/" class="toc-item">54. Prevention of Venous Thrombosis and Pulmonary Embolism: National Institutes of Health Consensus Development Conference Statement, March 24-26, 1986</a><ul id="toc_lst_NBK15127_A51602" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A51602"><a href="/books/n/hsnihcdc/A51600/#A51602" class="toc-item">Introduction and Overview</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51607"><a href="/books/n/hsnihcdc/A51600/#A51607" class="toc-item">What Is the Level of Risk of Venous Thrombosis and Embolism in Various Patient
|
|
Groups?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51638"><a href="/books/n/hsnihcdc/A51600/#A51638" class="toc-item">What Is the Efficacy and Safety of Various Forms of Prophylaxis in These Patient
|
|
Groups?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51646"><a href="/books/n/hsnihcdc/A51600/#A51646" class="toc-item">What Are the Recommended Forms of Prophylaxis in These Patient Groups?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51654"><a href="/books/n/hsnihcdc/A51600/#A51654" class="toc-item">What Questions Remain To Be Answered About Prophylaxis of Venous Thromboembolism?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51664"><a href="/books/n/hsnihcdc/A51600/#A51664" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51672"><a href="/books/n/hsnihcdc/A51600/#A51672" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51748"><a href="/books/n/hsnihcdc/A51600/#A51748" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51856"><a href="/books/n/hsnihcdc/A51600/#A51856" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51913"><a href="/books/n/hsnihcdc/A51600/#A51913" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51920"><a href="/books/n/hsnihcdc/A51600/#A51920" class="toc-item">
|
|
Supplemental Information for NIH Consensus Statement on
|
|
Electroconvulsive Therapy</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A51293"><a href="/books/n/hsnihcdc/A51293/" class="toc-item">53. Health Implications of Smokeless Tobacco Use: National Institutes of Health Consensus Development Conference Statement, January 13-15, 1986</a><ul id="toc_lst_NBK15127_A51295" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A51295"><a href="/books/n/hsnihcdc/A51293/#A51295" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51301"><a href="/books/n/hsnihcdc/A51293/#A51301" class="toc-item">What Are the Current Trends in the Use of Smokeless Tobacco in the United States?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51302"><a href="/books/n/hsnihcdc/A51293/#A51302" class="toc-item">Does the Use of Smokeless Tobacco Increase the Risk of Oral or Other Cancers?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51307"><a href="/books/n/hsnihcdc/A51293/#A51307" class="toc-item">Does the Use of Smokeless Tobacco Increase the Risk of Periodontal Disease or Other Oral and Health Problems?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51312"><a href="/books/n/hsnihcdc/A51293/#A51312" class="toc-item">What Are the Behavioral Consequences of Smokeless Tobacco Use?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51315"><a href="/books/n/hsnihcdc/A51293/#A51315" class="toc-item">What Issues Regarding the Health Consequences of Smokeless Tobacco Use Require Further Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51327"><a href="/books/n/hsnihcdc/A51293/#A51327" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51328"><a href="/books/n/hsnihcdc/A51293/#A51328" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51398"><a href="/books/n/hsnihcdc/A51293/#A51398" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51528"><a href="/books/n/hsnihcdc/A51293/#A51528" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51590"><a href="/books/n/hsnihcdc/A51293/#A51590" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A51146"><a href="/books/n/hsnihcdc/A51146/" class="toc-item">52. Adjuvant Chemotherapy for Breast Cancer: National Institutes of Health Consensus Development Conference Statement, September 9-11, 1985</a><ul id="toc_lst_NBK15127_A51148" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A51148"><a href="/books/n/hsnihcdc/A51146/#A51148" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51157"><a href="/books/n/hsnihcdc/A51146/#A51157" class="toc-item">Have Adjuvant Chemotherapy Trials in Breast Cancer Demonstrated an Increase in Survival in Any Group of Patients?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51160"><a href="/books/n/hsnihcdc/A51146/#A51160" class="toc-item">What Is the Role of Endocrine Treatment in the Adjuvant Therapy of Breast Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51163"><a href="/books/n/hsnihcdc/A51146/#A51163" class="toc-item">When Should Women With Histologically Negative Axillary Lymph Nodes Receive Adjuvant Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51164"><a href="/books/n/hsnihcdc/A51146/#A51164" class="toc-item">Are There Significant Adverse Effects of Adjuvant Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51165"><a href="/books/n/hsnihcdc/A51146/#A51165" class="toc-item">What Directions for Future Research Are Indicated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51173"><a href="/books/n/hsnihcdc/A51146/#A51173" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51179"><a href="/books/n/hsnihcdc/A51146/#A51179" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51235"><a href="/books/n/hsnihcdc/A51146/#A51235" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51286"><a href="/books/n/hsnihcdc/A51146/#A51286" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A1409"><a href="/books/n/hsnihcdc/A1409/" class="toc-item">51. Electroconvulsive Therapy: National Institutes of Health Consensus Development Conference Statement June 10-12, 1985</a><ul id="toc_lst_NBK15127_A1411" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A1411"><a href="/books/n/hsnihcdc/A1409/#A1411" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1417"><a href="/books/n/hsnihcdc/A1409/#A1417" class="toc-item">What Is the Evidence That ECT Is Effective for Patients With Specific Mental Disorders?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1425"><a href="/books/n/hsnihcdc/A1409/#A1425" class="toc-item">What Are the Risks and Adverse Effects of ECT?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1426"><a href="/books/n/hsnihcdc/A1409/#A1426" class="toc-item">What Factors Should Be Considered by the Physician and Patient in Determining If and When ECT Would Be an Appropriate Treatment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1431"><a href="/books/n/hsnihcdc/A1409/#A1431" class="toc-item">How Should ECT Be Administered To Maximize Benefits and Minimize Risks?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1432"><a href="/books/n/hsnihcdc/A1409/#A1432" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1438"><a href="/books/n/hsnihcdc/A1409/#A1438" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1439"><a href="/books/n/hsnihcdc/A1409/#A1439" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1523"><a href="/books/n/hsnihcdc/A1409/#A1523" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1650"><a href="/books/n/hsnihcdc/A1409/#A1650" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1727"><a href="/books/n/hsnihcdc/A1409/#A1727" class="toc-item">Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1733"><a href="/books/n/hsnihcdc/A1409/#A1733" class="toc-item">Supplemental Information for NIH Consensus Statement on Electroconvulsive Therapy</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A50834"><a href="/books/n/hsnihcdc/A50834/" class="toc-item">50. Anesthesia and Sedation in the Dental Office: National Institutes of Health Consensus Development Conference Statement, April 22-24, 1985</a><ul id="toc_lst_NBK15127_A50836" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A50836"><a href="/books/n/hsnihcdc/A50834/#A50836" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50843"><a href="/books/n/hsnihcdc/A50834/#A50843" class="toc-item">What Are the Differences Between General Anesthesia, Deep Sedation, and Conscious Sedation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50846"><a href="/books/n/hsnihcdc/A50834/#A50846" class="toc-item">What Are the Indications and Contraindications for the Use of General Anesthesia and Sedation in Children, Adults, and the Geriatric Population?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50850"><a href="/books/n/hsnihcdc/A50834/#A50850" class="toc-item">What Are the Appropriate Agents and Techniques for General Anesthesia and Sedation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50851"><a href="/books/n/hsnihcdc/A50834/#A50851" class="toc-item">What Are the Risks Associated With the Use of General Anesthesia and Sedation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50852"><a href="/books/n/hsnihcdc/A50834/#A50852" class="toc-item">What Facilities, Equipment, Personnel, and Training Are Needed for Managing and Monitoring Patients?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50857"><a href="/books/n/hsnihcdc/A50834/#A50857" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50879"><a href="/books/n/hsnihcdc/A50834/#A50879" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50880"><a href="/books/n/hsnihcdc/A50834/#A50880" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50956"><a href="/books/n/hsnihcdc/A50834/#A50956" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51062"><a href="/books/n/hsnihcdc/A50834/#A51062" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A51136"><a href="/books/n/hsnihcdc/A50834/#A51136" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A1093"><a href="/books/n/hsnihcdc/A1093/" class="toc-item">49. Health Implications of Obesity: National Institutes of Health Consensus Development Conference Statement February 11-13, 1985</a><ul id="toc_lst_NBK15127_A1095" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A1095"><a href="/books/n/hsnihcdc/A1093/#A1095" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1102"><a href="/books/n/hsnihcdc/A1093/#A1102" class="toc-item">What Is Obesity?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1103"><a href="/books/n/hsnihcdc/A1093/#A1103" class="toc-item">What Is the Evidence That Obesity Has Adverse Effects on Health?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1107"><a href="/books/n/hsnihcdc/A1093/#A1107" class="toc-item">What Is the Evidence That Obesity Affects Longevity?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1109"><a href="/books/n/hsnihcdc/A1093/#A1109" class="toc-item">What Are the Appropriate Uses and Limitations of Existing Height-Weight Tables?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1126"><a href="/books/n/hsnihcdc/A1093/#A1126" class="toc-item">For What Medical Conditions Can Weight Reduction Be Recommended?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1135"><a href="/books/n/hsnihcdc/A1093/#A1135" class="toc-item">What Should Be the Directions of Future Research in This Area?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1147"><a href="/books/n/hsnihcdc/A1093/#A1147" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1148"><a href="/books/n/hsnihcdc/A1093/#A1148" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1217"><a href="/books/n/hsnihcdc/A1093/#A1217" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1332"><a href="/books/n/hsnihcdc/A1093/#A1332" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1399"><a href="/books/n/hsnihcdc/A1093/#A1399" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A816"><a href="/books/n/hsnihcdc/A816/" class="toc-item">48. Travelers' Diarrhea: National Institutes of Health Consensus Development Conference Statement January 28-30, 1985</a><ul id="toc_lst_NBK15127_A818" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A818"><a href="/books/n/hsnihcdc/A816/#A818" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A824"><a href="/books/n/hsnihcdc/A816/#A824" class="toc-item">What Is the Epidemiology of Travelers' Diarrhea, and Why Is It Important?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A825"><a href="/books/n/hsnihcdc/A816/#A825" class="toc-item">What Causes Travelers' Diarrhea?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A833"><a href="/books/n/hsnihcdc/A816/#A833" class="toc-item">What Prevention Measures Are Effective for Travelers' Diarrhea?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A834"><a href="/books/n/hsnihcdc/A816/#A834" class="toc-item">What Treatment Measures Are Effective for Travelers' Diarrhea?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A845"><a href="/books/n/hsnihcdc/A816/#A845" class="toc-item">What Should Be the Direction of Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A862"><a href="/books/n/hsnihcdc/A816/#A862" class="toc-item">Summary and Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A863"><a href="/books/n/hsnihcdc/A816/#A863" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A927"><a href="/books/n/hsnihcdc/A816/#A927" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1020"><a href="/books/n/hsnihcdc/A816/#A1020" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1083"><a href="/books/n/hsnihcdc/A816/#A1083" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A1090"><a href="/books/n/hsnihcdc/A816/#A1090" class="toc-item">Supplemental Information for NIH Consensus Statement on Travelers' Diarrhea</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A50498"><a href="/books/n/hsnihcdc/A50498/" class="toc-item">47. Lowering Blood Cholesterol To Prevent Heart Disease: National Institutes of Health Consensus Development Conference Statement, December 10-12, 1984</a><ul id="toc_lst_NBK15127_A50500" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A50500"><a href="/books/n/hsnihcdc/A50498/#A50500" class="toc-item">Introduction and Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50519"><a href="/books/n/hsnihcdc/A50498/#A50519" class="toc-item">Is the Relationship Between Blood Cholesterol Levels and Coronary Heart Disease
|
|
Causal?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50533"><a href="/books/n/hsnihcdc/A50498/#A50533" class="toc-item">Will Reduction of Cholesterol Levels Help Prevent Coronary Heart Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50534"><a href="/books/n/hsnihcdc/A50498/#A50534" class="toc-item">Under What Circumstances and at What Level of Blood Cholesterol Should Dietary or
|
|
Drug Treatment Be Started?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50544"><a href="/books/n/hsnihcdc/A50498/#A50544" class="toc-item">Should an Attempt Be Made To Reduce the Blood Cholesterol of the General Population?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50546"><a href="/books/n/hsnihcdc/A50498/#A50546" class="toc-item">Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50557"><a href="/books/n/hsnihcdc/A50498/#A50557" class="toc-item">What Research Directions Should Be Pursued on the Relationship Between Cholesterol
|
|
and Heart Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50566"><a href="/books/n/hsnihcdc/A50498/#A50566" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50637"><a href="/books/n/hsnihcdc/A50498/#A50637" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50780"><a href="/books/n/hsnihcdc/A50498/#A50780" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50825"><a href="/books/n/hsnihcdc/A50498/#A50825" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A50212"><a href="/books/n/hsnihcdc/A50212/" class="toc-item">46. Limb-Sparing Treatment of Adult Soft-Tissue Sarcomas and Osteosarcomas: National Institutes of Health Consensus Development Conference Statement, December 3-5, 1984</a><ul id="toc_lst_NBK15127_A50214" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A50214"><a href="/books/n/hsnihcdc/A50212/#A50214" class="toc-item">Introduction and Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50222"><a href="/books/n/hsnihcdc/A50212/#A50222" class="toc-item">What Is the Optimal Pretreatment Evaluation of the Sarcoma Patient Regarding Diagnosis, Extent of Disease Workup, and Staging?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50227"><a href="/books/n/hsnihcdc/A50212/#A50227" class="toc-item">Are There Types of Patients for Whom Limb-Sparing Treatment Should Be Considered Appropriate Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50228"><a href="/books/n/hsnihcdc/A50212/#A50228" class="toc-item">If So, What Is the Optimal Limb-Sparing Treatment Strategy? Consider the Following: Indications and Contraindications, Extent of Surgical Resection, Need for and Form of Radiation Therapy and/or Chemotherapy, Treatment Morbidity and Function of the Limb, and End Results?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50242"><a href="/books/n/hsnihcdc/A50212/#A50242" class="toc-item">Are There Types of Extremity Sarcoma Patients for Whom Adjuvant Systemic Chemotherapy Is Indicated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50243"><a href="/books/n/hsnihcdc/A50212/#A50243" class="toc-item">What Directions Should Be Taken for Future Research on the Treatment of Extremity Sarcomas?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50253"><a href="/books/n/hsnihcdc/A50212/#A50253" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50323"><a href="/books/n/hsnihcdc/A50212/#A50323" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50424"><a href="/books/n/hsnihcdc/A50212/#A50424" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50491"><a href="/books/n/hsnihcdc/A50212/#A50491" class="toc-item">Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A562"><a href="/books/n/hsnihcdc/A562/" class="toc-item">45. Fresh Frozen Plasma: Indications and Risks: National Institutes of Health Consensus Development Conference Statement September 24-26, 1984</a><ul id="toc_lst_NBK15127_A564" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A564"><a href="/books/n/hsnihcdc/A562/#A564" class="toc-item">Introduction and Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A570"><a href="/books/n/hsnihcdc/A562/#A570" class="toc-item">Panel's Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A571"><a href="/books/n/hsnihcdc/A562/#A571" class="toc-item">What Are the Currently Recommended Clinical Indications for FFP?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A578"><a href="/books/n/hsnihcdc/A562/#A578" class="toc-item">What Are the Risks of FFP?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A579"><a href="/books/n/hsnihcdc/A562/#A579" class="toc-item">What Alternative Therapies Exist?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A580"><a href="/books/n/hsnihcdc/A562/#A580" class="toc-item">What Is the Current Scientific Knowledge Regarding the Effectiveness of FFP?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A581"><a href="/books/n/hsnihcdc/A562/#A581" class="toc-item">What Directions for Future Research Are Indicated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A592"><a href="/books/n/hsnihcdc/A562/#A592" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A648"><a href="/books/n/hsnihcdc/A562/#A648" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A744"><a href="/books/n/hsnihcdc/A562/#A744" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A805"><a href="/books/n/hsnihcdc/A562/#A805" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A815"><a href="/books/n/hsnihcdc/A562/#A815" class="toc-item">Supplemental Information for NIH Consensus Statement on Fresh Frozen Plasma: Indications and Risks</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A264"><a href="/books/n/hsnihcdc/A264/" class="toc-item">44. Mood Disorders: Pharmacologic Prevention of Recurrences: National Institutes of Health Consensus Development Conference Statement April 24-26, 1984</a><ul id="toc_lst_NBK15127_A266" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A266"><a href="/books/n/hsnihcdc/A264/#A266" class="toc-item">Introduction and Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A276"><a href="/books/n/hsnihcdc/A264/#A276" class="toc-item">How Common Are Recurrent Mood Disorders, and What Are the Variations in the Course of These Illnesses?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A280"><a href="/books/n/hsnihcdc/A264/#A280" class="toc-item">What Groups of Patients With Mood Disorders Should Be Considered for Preventive Maintenance Medication?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A284"><a href="/books/n/hsnihcdc/A264/#A284" class="toc-item">How Effective Are These Medications in Modifying the Course of Recurrent Affective Illness?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A287"><a href="/books/n/hsnihcdc/A264/#A287" class="toc-item">What Principles Guide Selection of Specific Therapeutic Agents for These Groups?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A290"><a href="/books/n/hsnihcdc/A264/#A290" class="toc-item">What Are the Treatment Strategies for Using These Medications on a Long-Term Basis? What Additional or Alternative Strategies Are Available for Breakthrough Episodes, Treatment Failures, or Aspects of the Illness Unresponsive to Medication?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A296"><a href="/books/n/hsnihcdc/A264/#A296" class="toc-item">What Are the Long-term Risks and Complications of Preventive Therapy? How Should These Be Assessed and Managed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A299"><a href="/books/n/hsnihcdc/A264/#A299" class="toc-item">What Research Areas Need Further Development?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A303"><a href="/books/n/hsnihcdc/A264/#A303" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A376"><a href="/books/n/hsnihcdc/A264/#A376" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A489"><a href="/books/n/hsnihcdc/A264/#A489" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A548"><a href="/books/n/hsnihcdc/A264/#A548" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A553"><a href="/books/n/hsnihcdc/A264/#A553" class="toc-item">Supplemental Information for NIH Consensus Statement on Mood Disorders: Pharmacologic Prevention of Recurrences</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A49934"><a href="/books/n/hsnihcdc/A49934/" class="toc-item">43. Osteoporosis: National Institutes of Health Consensus Development Conference Statement, April 2-4, 1984</a><ul id="toc_lst_NBK15127_A49936" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A49936"><a href="/books/n/hsnihcdc/A49934/#A49936" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49944"><a href="/books/n/hsnihcdc/A49934/#A49944" class="toc-item">What Is Osteoporosis?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49945"><a href="/books/n/hsnihcdc/A49934/#A49945" class="toc-item">What Are the Clinical Features of Osteoporosis, and How Is It Detected?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49946"><a href="/books/n/hsnihcdc/A49934/#A49946" class="toc-item">Who Is At Risk for Developing Osteoporosis?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49947"><a href="/books/n/hsnihcdc/A49934/#A49947" class="toc-item">What Are the Possible Causes of Osteoporosis?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49948"><a href="/books/n/hsnihcdc/A49934/#A49948" class="toc-item">How Can Osteoporosis Be Prevented and Treated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49949"><a href="/books/n/hsnihcdc/A49934/#A49949" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49957"><a href="/books/n/hsnihcdc/A49934/#A49957" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50028"><a href="/books/n/hsnihcdc/A49934/#A50028" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50147"><a href="/books/n/hsnihcdc/A49934/#A50147" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50204"><a href="/books/n/hsnihcdc/A49934/#A50204" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A50209"><a href="/books/n/hsnihcdc/A49934/#A50209" class="toc-item">Supplemental Information for NIH Consensus Statement on Osteoporosis</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A49679"><a href="/books/n/hsnihcdc/A49679/" class="toc-item">42. Analgesic-Associated Kidney Disease: National Institutes of Health Consensus Development Conference Statement, February 27-29, 1984</a><ul id="toc_lst_NBK15127_A49681" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A49681"><a href="/books/n/hsnihcdc/A49679/#A49681" class="toc-item">Introduction and Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49691"><a href="/books/n/hsnihcdc/A49679/#A49691" class="toc-item">Can Analgesics, Alone or in Combination, Cause Kidney Disease and Chronic Renal Failure? What Evidence Supports These Conclusions?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49695"><a href="/books/n/hsnihcdc/A49679/#A49695" class="toc-item">What Are the Scope and Characteristics of the Problem of Kidney Disease Caused by Excessive Use of Analgesics in the United States and in Other Countries?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49699"><a href="/books/n/hsnihcdc/A49679/#A49699" class="toc-item">What Causes Analgesic-Associated Kidney Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49700"><a href="/books/n/hsnihcdc/A49679/#A49700" class="toc-item">What Factors Increase the Risk of Its Occurrence?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49701"><a href="/books/n/hsnihcdc/A49679/#A49701" class="toc-item">Can It Be Prevented?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49702"><a href="/books/n/hsnihcdc/A49679/#A49702" class="toc-item">What Treatment Strategies Are Appropriate?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49709"><a href="/books/n/hsnihcdc/A49679/#A49709" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49710"><a href="/books/n/hsnihcdc/A49679/#A49710" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49772"><a href="/books/n/hsnihcdc/A49679/#A49772" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49854"><a href="/books/n/hsnihcdc/A49679/#A49854" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49927"><a href="/books/n/hsnihcdc/A49679/#A49927" class="toc-item">Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A49461"><a href="/books/n/hsnihcdc/A49461/" class="toc-item">41. Diagnostic Ultrasound Imaging in Pregnancy: National Institutes of Health Consensus Development Conference Statement, February 6-8, 1984</a><ul id="toc_lst_NBK15127_A49463" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A49463"><a href="/books/n/hsnihcdc/A49461/#A49463" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49469"><a href="/books/n/hsnihcdc/A49461/#A49469" class="toc-item">What Types of Ultrasound Scanning Are Currently Used in Obstetric Practice? How Extensive Is This Use? What Is Known About the Dose/Exposure to the Fetus and the Mother From Each Type?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49470"><a href="/books/n/hsnihcdc/A49461/#A49470" class="toc-item">For What Purposes Is Ultrasound Now Used in Pregnancy? For Each Use, What Is the Evidence That Ultrasound Improves Patient Management and/or Outcome of Pregnancy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49499"><a href="/books/n/hsnihcdc/A49461/#A49499" class="toc-item">What Are the Theoretical Risks of Ultrasound to the Fetus and the Mother? What Evidence Exists From Animal, Tissue Culture, and Human Studies on the Actual Extent of the Risk?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49500"><a href="/books/n/hsnihcdc/A49461/#A49500" class="toc-item">Based on the Available Evidence, What Are the Appropriate Indications for, and the Limitations on, Use of Ultrasound in Obstetrics Today?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49501"><a href="/books/n/hsnihcdc/A49461/#A49501" class="toc-item">What Further Studies Are Needed of Efficacy and Safety of Use of Ultrasound in Pregnancy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49507"><a href="/books/n/hsnihcdc/A49461/#A49507" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49580"><a href="/books/n/hsnihcdc/A49461/#A49580" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49599"><a href="/books/n/hsnihcdc/A49461/#A49599" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49666"><a href="/books/n/hsnihcdc/A49461/#A49666" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A5"><a href="/books/n/hsnihcdc/A5/" class="toc-item">40. Dental Sealants in the Prevention of Tooth Decay: National Institutes of Health Consensus Development Conference Statement December 5-7, 1983</a><ul id="toc_lst_NBK15127_A7" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A7"><a href="/books/n/hsnihcdc/A5/#A7" class="toc-item">Introduction and Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A17"><a href="/books/n/hsnihcdc/A5/#A17" class="toc-item">With the Current Widespread Use of Fluorides and the Generalized Decrease in Caries Experience Among Children, Is There a Need for Sealants?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A18"><a href="/books/n/hsnihcdc/A5/#A18" class="toc-item">How Effective Are Sealants?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A19"><a href="/books/n/hsnihcdc/A5/#A19" class="toc-item">Are There Risks Associated With the Use of Sealants?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A20"><a href="/books/n/hsnihcdc/A5/#A20" class="toc-item">What Are the Indications for Using Sealants in Individual and Community-Based Caries Preventive Programs?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A28"><a href="/books/n/hsnihcdc/A5/#A28" class="toc-item">What Are the Clinical Procedures Involved in Successful Sealant Application, and What Training and Education Are Required?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A38"><a href="/books/n/hsnihcdc/A5/#A38" class="toc-item">What Factors Have Influenced and Should Influence the Adoption and Utilization of Sealants for Caries Prevention?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A60"><a href="/books/n/hsnihcdc/A5/#A60" class="toc-item">What Is the Current Status of Sealant Research and What Should Be the Research Priorities for Sealants and Their Implementation</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A73"><a href="/books/n/hsnihcdc/A5/#A73" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A121"><a href="/books/n/hsnihcdc/A5/#A121" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A208"><a href="/books/n/hsnihcdc/A5/#A208" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A259"><a href="/books/n/hsnihcdc/A5/#A259" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A49185"><a href="/books/n/hsnihcdc/A49185/" class="toc-item">39. Drugs and Insomnia: The Use of Medications to Promote Sleep: National Institutes of Health Consensus Development Conference Statement, November 15-17, 1983</a><ul id="toc_lst_NBK15127_A49187" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A49187"><a href="/books/n/hsnihcdc/A49185/#A49187" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49193"><a href="/books/n/hsnihcdc/A49185/#A49193" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49194"><a href="/books/n/hsnihcdc/A49185/#A49194" class="toc-item">Under What Circumstances Might a Sleep-Promoting Medication Be Considered; In What Types of Sleep Disturbances Are Sleep-Promoting Medications Undesirable?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49195"><a href="/books/n/hsnihcdc/A49185/#A49195" class="toc-item">What Are the Pharmacologic Factors To Be Considered in the Selection of Sleep-Promoting Medications?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49196"><a href="/books/n/hsnihcdc/A49185/#A49196" class="toc-item">What Are the Appropriate Treatment Strategies To Be Employed in Using Sleep-Promoting Medications on a Short-Term or Long-Term Basis?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49197"><a href="/books/n/hsnihcdc/A49185/#A49197" class="toc-item">What Are the Principal Cautions and Risks Associated With Prescribing These Drugs; What Special Considerations Should Be Applied in Regard to Medical Status, Age, Concurrent Drug Use, or Other Factors?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49198"><a href="/books/n/hsnihcdc/A49185/#A49198" class="toc-item">What Research Areas Need Further Development?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49199"><a href="/books/n/hsnihcdc/A49185/#A49199" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49271"><a href="/books/n/hsnihcdc/A49185/#A49271" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49401"><a href="/books/n/hsnihcdc/A49185/#A49401" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49456"><a href="/books/n/hsnihcdc/A49185/#A49456" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A48887"><a href="/books/n/hsnihcdc/A48887/" class="toc-item">38. Precursors to Malignant Melanoma: National Institutes of Health Consensus Development Conference Statement, October 24-26, 1983</a><ul id="toc_lst_NBK15127_A48889" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A48889"><a href="/books/n/hsnihcdc/A48887/#A48889" class="toc-item">Introduction and Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48896"><a href="/books/n/hsnihcdc/A48887/#A48896" class="toc-item">Can Dysplastic Nevi and Congenital Nevi Be Defined Clinically and Histologically?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48913"><a href="/books/n/hsnihcdc/A48887/#A48913" class="toc-item">Are These Nevi Precursors to Melanoma? What Are the Prevalence, Natural History, and Determinants of These Precursors?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48916"><a href="/books/n/hsnihcdc/A48887/#A48916" class="toc-item">What Is Appropriate Management of Patients With "Dysplastic" Nevi and Congenital Nevi Regarding: Diagnosis, Treatment, Followup, Familial Screening, and Education?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48925"><a href="/books/n/hsnihcdc/A48887/#A48925" class="toc-item">What Directions Should Be Taken for Future Research on Precursor Lesions to Melanoma?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48937"><a href="/books/n/hsnihcdc/A48887/#A48937" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49000"><a href="/books/n/hsnihcdc/A48887/#A49000" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49123"><a href="/books/n/hsnihcdc/A48887/#A49123" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A49178"><a href="/books/n/hsnihcdc/A48887/#A49178" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A48608"><a href="/books/n/hsnihcdc/A48608/" class="toc-item">37. Treatment of Hypertriglyceridemia: National Institutes of Health Consensus Development Conference Statement, September 27-29, 1983</a><ul id="toc_lst_NBK15127_A48610" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A48610"><a href="/books/n/hsnihcdc/A48608/#A48610" class="toc-item">Introduction and Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48619"><a href="/books/n/hsnihcdc/A48608/#A48619" class="toc-item">What Is Hypertriglyceridemia?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48620"><a href="/books/n/hsnihcdc/A48608/#A48620" class="toc-item">What Is the Evidence That Plasma Triglycerides Are Associated With Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48621"><a href="/books/n/hsnihcdc/A48608/#A48621" class="toc-item">What Patients With Hypertriglyceridemia Are Candidates for Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48626"><a href="/books/n/hsnihcdc/A48608/#A48626" class="toc-item">What Can Be Achieved With Dietary and Other Therapies?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48631"><a href="/books/n/hsnihcdc/A48608/#A48631" class="toc-item">What Should Be the Guidelines for Dietary and Drug Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48640"><a href="/books/n/hsnihcdc/A48608/#A48640" class="toc-item">What Should Be the Direction for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48650"><a href="/books/n/hsnihcdc/A48608/#A48650" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48709"><a href="/books/n/hsnihcdc/A48608/#A48709" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48833"><a href="/books/n/hsnihcdc/A48608/#A48833" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48880"><a href="/books/n/hsnihcdc/A48608/#A48880" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A48292"><a href="/books/n/hsnihcdc/A48292/" class="toc-item">36. Liver Transplantation: National Institutes of Health Consensus Development Conference Statement, June 20-23, 1983</a><ul id="toc_lst_NBK15127_A48294" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A48294"><a href="/books/n/hsnihcdc/A48292/#A48294" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48300"><a href="/books/n/hsnihcdc/A48292/#A48300" class="toc-item">Are There Groups of Patients for Whom Transplantation of the Liver Should Be Considered Appropriate Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48309"><a href="/books/n/hsnihcdc/A48292/#A48309" class="toc-item">What Is the Outcome (Current Survival Rates, Complications) in Different Groups?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48317"><a href="/books/n/hsnihcdc/A48292/#A48317" class="toc-item">In a Potential Candidate for Transplantation, What Are the Principles Guiding Selection of the Appropriate Time for Surgery?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48331"><a href="/books/n/hsnihcdc/A48292/#A48331" class="toc-item">What Are the Skills, Resources, and Institutional Support Needed for Liver Transplantation?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48332"><a href="/books/n/hsnihcdc/A48292/#A48332" class="toc-item">What Are the Directions for Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48333"><a href="/books/n/hsnihcdc/A48292/#A48333" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48334"><a href="/books/n/hsnihcdc/A48292/#A48334" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48418"><a href="/books/n/hsnihcdc/A48292/#A48418" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48560"><a href="/books/n/hsnihcdc/A48292/#A48560" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48599"><a href="/books/n/hsnihcdc/A48292/#A48599" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A47920"><a href="/books/n/hsnihcdc/A47920/" class="toc-item">35. Critical Care Medicine: National Institutes of Health Consensus Development Conference Statement, March 7-9, 1983</a><ul id="toc_lst_NBK15127_A47922" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A47922"><a href="/books/n/hsnihcdc/A47920/#A47922" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47929"><a href="/books/n/hsnihcdc/A47920/#A47929" class="toc-item">Is There Empirical Evidence That Intensive Care Units Cause a Decrease in Patient Morbidity or Mortality? Which Patients Are Most Likely To Benefit From Intensive Care?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47930"><a href="/books/n/hsnihcdc/A47920/#A47930" class="toc-item">What Skills Are Essential for Personnel in a Critical Care Unit? How Should This Personnel Be Trained and Organized to Assure the Best Care for Patients Most in Need?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47942"><a href="/books/n/hsnihcdc/A47920/#A47942" class="toc-item">What Special Technology and Therapeutic Interventions Should Be Routinely Available for the Most Effective ICU Function?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47953"><a href="/books/n/hsnihcdc/A47920/#A47953" class="toc-item">How Is a Hospital's Critical Care Delivery System Best Structured: One Large Multispecialty Unit or Multiple Small Subspecialty Intensive Care Units?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47958"><a href="/books/n/hsnihcdc/A47920/#A47958" class="toc-item">How Has the Development of Intensive Care Units Affected the Traditional Functions of a Hospital?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47959"><a href="/books/n/hsnihcdc/A47920/#A47959" class="toc-item">What Direction Should Critical Care Research Follow?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47969"><a href="/books/n/hsnihcdc/A47920/#A47969" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48067"><a href="/books/n/hsnihcdc/A47920/#A48067" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48241"><a href="/books/n/hsnihcdc/A47920/#A48241" class="toc-item">Planning Committee</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A48283"><a href="/books/n/hsnihcdc/A47920/#A48283" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A47589"><a href="/books/n/hsnihcdc/A47589/" class="toc-item">34. Clinical Applications of Biomaterials: National Institutes of Health Consensus Development Conference Statement, November 1-3, 1982</a><ul id="toc_lst_NBK15127_A47591" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A47591"><a href="/books/n/hsnihcdc/A47589/#A47591" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47597"><a href="/books/n/hsnihcdc/A47589/#A47597" class="toc-item">How Safe and Effective Are Biomaterials Currently in Clinical Use?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47598"><a href="/books/n/hsnihcdc/A47589/#A47598" class="toc-item">How Well Can We Predict Biological Performance of Materials in the Human Body: Host Response, Biomaterials Response?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47599"><a href="/books/n/hsnihcdc/A47589/#A47599" class="toc-item">What Results of Ongoing Research in Materials Science Would Potentially Be Applicable to Clinical Care?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47620"><a href="/books/n/hsnihcdc/A47589/#A47620" class="toc-item">Are the Ways for Introducing Biomaterials Into Medical Use Responsive to Current Clinical Needs? Which Elements in the Process Are Amenable to Improvements?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47633"><a href="/books/n/hsnihcdc/A47589/#A47633" class="toc-item">What Are the Areas of Greatest Clinical Need for New Biomaterials?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47639"><a href="/books/n/hsnihcdc/A47589/#A47639" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47640"><a href="/books/n/hsnihcdc/A47589/#A47640" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47720"><a href="/books/n/hsnihcdc/A47589/#A47720" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47910"><a href="/books/n/hsnihcdc/A47589/#A47910" class="toc-item">Conference Coordinator</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47917"><a href="/books/n/hsnihcdc/A47589/#A47917" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A47260"><a href="/books/n/hsnihcdc/A47260/" class="toc-item">33. Total Hip Joint Replacement: National Institutes of Health Consensus Development Conference Statement, March 1-3, 1982</a><ul id="toc_lst_NBK15127_A47262" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A47262"><a href="/books/n/hsnihcdc/A47260/#A47262" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47269"><a href="/books/n/hsnihcdc/A47260/#A47269" class="toc-item">What Are the Indications and Contraindications for Total Hip Joint Replacement?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47272"><a href="/books/n/hsnihcdc/A47260/#A47272" class="toc-item">What Are the Current Scientific Principles Guiding Selection of Materials, Devices, and Procedures for Total Hip Joint Replacement?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47275"><a href="/books/n/hsnihcdc/A47260/#A47275" class="toc-item">What is the Short-Term and Long-Term Prognosis for Medical Status and Functional Activity After Total Hip Joint Replacement?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47276"><a href="/books/n/hsnihcdc/A47260/#A47276" class="toc-item">What Are the Medical and Surgical Complications of Total Hip Joint Replacement?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47286"><a href="/books/n/hsnihcdc/A47260/#A47286" class="toc-item">What Are the Problems Related to Revision Surgery for Total Hip Joint Replacement?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47287"><a href="/books/n/hsnihcdc/A47260/#A47287" class="toc-item">In What Directions Should the Science Base and Techniques of Total Hip Joint Replacement Be Advanced?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47288"><a href="/books/n/hsnihcdc/A47260/#A47288" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47373"><a href="/books/n/hsnihcdc/A47260/#A47373" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47585"><a href="/books/n/hsnihcdc/A47260/#A47585" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A47084"><a href="/books/n/hsnihcdc/A47084/" class="toc-item">32. Defined Diets and Childhood Hyperactivity: National Institutes of Health Consensus Development Conference Statement, January 13-15, 1982</a><ul id="toc_lst_NBK15127_A47086" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A47086"><a href="/books/n/hsnihcdc/A47084/#A47086" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47093"><a href="/books/n/hsnihcdc/A47084/#A47093" class="toc-item">What Constitutes the Hyperactivity Syndrome in Children? Is It a Single Disease or a Cluster of Diseases? Can It Be Graded or Scaled in Quantifiable Variables Such as Attention Span, Learning Ability, and Social Adjustment and By Whom (Teachers, Parents, Medical Personnel)?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47094"><a href="/books/n/hsnihcdc/A47084/#A47094" class="toc-item">What Are the Defined Diets?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47095"><a href="/books/n/hsnihcdc/A47084/#A47095" class="toc-item">Is There Empirical Evidence for an Effect of These Diets on Hyperactivity?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47096"><a href="/books/n/hsnihcdc/A47084/#A47096" class="toc-item">Is There Any Biological Explanation to Support an Effect of Defined Diets on Hyperactivity?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47097"><a href="/books/n/hsnihcdc/A47084/#A47097" class="toc-item">If Defined Diets Are Effective, How and Under What Circumstances Should They Be Employed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47098"><a href="/books/n/hsnihcdc/A47084/#A47098" class="toc-item">What Are the Directions for Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47103"><a href="/books/n/hsnihcdc/A47084/#A47103" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47169"><a href="/books/n/hsnihcdc/A47084/#A47169" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47253"><a href="/books/n/hsnihcdc/A47084/#A47253" class="toc-item">Conference Coordinator</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47256"><a href="/books/n/hsnihcdc/A47084/#A47256" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A46994"><a href="/books/n/hsnihcdc/A46994/" class="toc-item">31. Computed Tomographic Scanning of the Brain: National Institutes of Health Consensus Development Conference Statement, November 4-6, 1981</a><ul id="toc_lst_NBK15127_A46996" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A46996"><a href="/books/n/hsnihcdc/A46994/#A46996" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47002"><a href="/books/n/hsnihcdc/A46994/#A47002" class="toc-item">What Are the Indications for Employing CT Scanning as a Primary or Secondary Diagnostic Tool for Intracranial Lesions?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47003"><a href="/books/n/hsnihcdc/A46994/#A47003" class="toc-item">Are There Specific Contraindications?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47004"><a href="/books/n/hsnihcdc/A46994/#A47004" class="toc-item">How Much Radiation Is Delivered During Use of Currently Available CT Scan Equipment, and How Is This Dosage Commonly Expressed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47007"><a href="/books/n/hsnihcdc/A46994/#A47007" class="toc-item">To What Extent Has CT Scanning Influenced the Management of Intracranial Disorders, Such as Malignancy, Trauma, Vascular Anomalies, and Cerebrovascular Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47008"><a href="/books/n/hsnihcdc/A46994/#A47008" class="toc-item">Has the Availability of CT Brain Scanning Influenced the Use of Other Methods for Imaging the Brain?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47009"><a href="/books/n/hsnihcdc/A46994/#A47009" class="toc-item">What Is the Practical Limit of Definition and Resolution in CT Scanning That May Preclude Its Value in the Diagnosis of Brain Disease?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47010"><a href="/books/n/hsnihcdc/A46994/#A47010" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A47080"><a href="/books/n/hsnihcdc/A46994/#A47080" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A46681"><a href="/books/n/hsnihcdc/A46681/" class="toc-item">30. The Diagnosis and Treatment of Reye's Syndrome: National Institutes of Health Consensus Development Conference Statement, March 2-4, 1981</a><ul id="toc_lst_NBK15127_A46683" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A46683"><a href="/books/n/hsnihcdc/A46681/#A46683" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46687"><a href="/books/n/hsnihcdc/A46681/#A46687" class="toc-item">What Are the Key Symptoms?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46688"><a href="/books/n/hsnihcdc/A46681/#A46688" class="toc-item">What Are the Laboratory Findings in Reye's Syndrome?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46689"><a href="/books/n/hsnihcdc/A46681/#A46689" class="toc-item">Where Should a Patient Be Treated?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46691"><a href="/books/n/hsnihcdc/A46681/#A46691" class="toc-item">What Are the Currently Used Rating or Classifying Systems for Measuring the
|
|
Severity of Clinical Symptoms? How Useful Are They?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46692"><a href="/books/n/hsnihcdc/A46681/#A46692" class="toc-item">Should a Uniform System Be Recommended for General Use?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46693"><a href="/books/n/hsnihcdc/A46681/#A46693" class="toc-item">When Is a Liver Biopsy Needed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46694"><a href="/books/n/hsnihcdc/A46681/#A46694" class="toc-item">What Other Conditions May Present With Similar Symptoms?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46695"><a href="/books/n/hsnihcdc/A46681/#A46695" class="toc-item">What Special Diagnostic Tests Are Needed?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46696"><a href="/books/n/hsnihcdc/A46681/#A46696" class="toc-item">What Have Been the Indications for Intracranial Pressure Monitoring? What Devices
|
|
Are Available? What Are the Goals in Reducing Intracranial Pressure and When Can
|
|
Monitoring Be Stopped?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46697"><a href="/books/n/hsnihcdc/A46681/#A46697" class="toc-item">What Are Appropriate Therapies in the Noncomatose Patient?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46698"><a href="/books/n/hsnihcdc/A46681/#A46698" class="toc-item">What Are the Important Metabolic Derangements and Are They Amenable to Treatment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46699"><a href="/books/n/hsnihcdc/A46681/#A46699" class="toc-item">What Are the Therapies for Increased Intracranial Pressure?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46700"><a href="/books/n/hsnihcdc/A46681/#A46700" class="toc-item">What Therapies Are Directed at Removal of Presumed Toxins?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46701"><a href="/books/n/hsnihcdc/A46681/#A46701" class="toc-item">What Are the Residual Findings?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46702"><a href="/books/n/hsnihcdc/A46681/#A46702" class="toc-item">What Are the Areas of Future Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46707"><a href="/books/n/hsnihcdc/A46681/#A46707" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46778"><a href="/books/n/hsnihcdc/A46681/#A46778" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46982"><a href="/books/n/hsnihcdc/A46681/#A46982" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A46481"><a href="/books/n/hsnihcdc/A46481/" class="toc-item">29. Coronary Artery Bypass Surgery: Scientific and Clinical Aspects: National Institutes of Health Consensus Development Conference Statement, December 3-5, 1980</a><ul id="toc_lst_NBK15127_A46483" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A46483"><a href="/books/n/hsnihcdc/A46481/#A46483" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46489"><a href="/books/n/hsnihcdc/A46481/#A46489" class="toc-item">What Is the Overall Management of Coronary Artery Disease—That Is, in What Context Should Coronary Artery Surgery Be Considered?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46490"><a href="/books/n/hsnihcdc/A46481/#A46490" class="toc-item">What Constitutes a Reasonable Diagnostic Workup Before Recommending Medical or Surgical Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46491"><a href="/books/n/hsnihcdc/A46481/#A46491" class="toc-item">What Is Known About Long-Term Survival After Coronary Artery Bypass Surgery in Specific Patient Groups?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46492"><a href="/books/n/hsnihcdc/A46481/#A46492" class="toc-item">What Is Known About the Long-Term Quality of Life After Coronary Artery Bypass Surgery?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46493"><a href="/books/n/hsnihcdc/A46481/#A46493" class="toc-item">What Is the Range of Success Rates for the Procedure in Various Settings, and What Factors May Be Important in Influencing This Outcome?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46494"><a href="/books/n/hsnihcdc/A46481/#A46494" class="toc-item">Conclusion</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46495"><a href="/books/n/hsnihcdc/A46481/#A46495" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46565"><a href="/books/n/hsnihcdc/A46481/#A46565" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46677"><a href="/books/n/hsnihcdc/A46481/#A46677" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A46289"><a href="/books/n/hsnihcdc/A46289/" class="toc-item">28. CEA (Carcinoembryonic Antigen): Its Role as a Marker in the Management of Cancer: National Institutes of Health Consensus Development Conference Statement, September 29-October 1, 1980</a><ul id="toc_lst_NBK15127_A46291" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A46291"><a href="/books/n/hsnihcdc/A46289/#A46291" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46297"><a href="/books/n/hsnihcdc/A46289/#A46297" class="toc-item">Conclusions and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46298"><a href="/books/n/hsnihcdc/A46289/#A46298" class="toc-item">Should CEA Be Used in Cancer Screening?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46299"><a href="/books/n/hsnihcdc/A46289/#A46299" class="toc-item">Is CEA Helpful in Cancer Diagnosis?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46300"><a href="/books/n/hsnihcdc/A46289/#A46300" class="toc-item">What Does CEA Tell About the Extent and Outcome of Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46301"><a href="/books/n/hsnihcdc/A46289/#A46301" class="toc-item">Is CEA Helpful in Monitoring Cancer Treatment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46303"><a href="/books/n/hsnihcdc/A46289/#A46303" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46336"><a href="/books/n/hsnihcdc/A46289/#A46336" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46471"><a href="/books/n/hsnihcdc/A46289/#A46471" class="toc-item">Conference Organizers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46478"><a href="/books/n/hsnihcdc/A46289/#A46478" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A46048"><a href="/books/n/hsnihcdc/A46048/" class="toc-item">27. Cesarean Childbirth: National Institutes of Health Consensus Development Conference Statement, September 22-24, 1980</a><ul id="toc_lst_NBK15127_A46050" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A46050"><a href="/books/n/hsnihcdc/A46048/#A46050" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46056"><a href="/books/n/hsnihcdc/A46048/#A46056" class="toc-item">Why and How Have Cesarean Delivery Rates Changed in the United States and Elsewhere,
|
|
and How Have These Changes Affected Pregnancy Outcome?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46059"><a href="/books/n/hsnihcdc/A46048/#A46059" class="toc-item">What Is the Evidence That Cesarean Delivery Improves the Outcome of Various
|
|
Complications of Pregnancy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46087"><a href="/books/n/hsnihcdc/A46048/#A46087" class="toc-item">What Are the Medical and Psychological Effects of Cesarean Delivery on the Mother,
|
|
Infant, and Family?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46114"><a href="/books/n/hsnihcdc/A46048/#A46114" class="toc-item">What Economic Factors Are Associated With Cesarean Births?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46118"><a href="/books/n/hsnihcdc/A46048/#A46118" class="toc-item">What Legal and Ethical Considerations Are Involved in Decisions on Cesarean
|
|
Delivery?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46127"><a href="/books/n/hsnihcdc/A46048/#A46127" class="toc-item">Consensus Development Panel ("Task Force")</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46241"><a href="/books/n/hsnihcdc/A46048/#A46241" class="toc-item">Members of the Panel of Review</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46285"><a href="/books/n/hsnihcdc/A46048/#A46285" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A45840"><a href="/books/n/hsnihcdc/A45840/" class="toc-item">26. Endoscopy in Upper GI Bleeding: National Institutes of Health Consensus Development Conference Statement, August 20-22, 1980</a><ul id="toc_lst_NBK15127_A45842" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A45842"><a href="/books/n/hsnihcdc/A45840/#A45842" class="toc-item">Note</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45847"><a href="/books/n/hsnihcdc/A45840/#A45847" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45848"><a href="/books/n/hsnihcdc/A45840/#A45848" class="toc-item">What Are the Benefits of Endoscopy in Upper GI Bleeding?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45849"><a href="/books/n/hsnihcdc/A45840/#A45849" class="toc-item">What Is the Place of Other Diagnostic Approaches to Upper GI Bleeding?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45853"><a href="/books/n/hsnihcdc/A45840/#A45853" class="toc-item">What Are The Considerations in the Decision Whether to Perform Endoscopy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45854"><a href="/books/n/hsnihcdc/A45840/#A45854" class="toc-item">What Are The Risks of Endoscopy in the Bleeding Patient?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45857"><a href="/books/n/hsnihcdc/A45840/#A45857" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45889"><a href="/books/n/hsnihcdc/A45840/#A45889" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A46043"><a href="/books/n/hsnihcdc/A45840/#A46043" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A45562"><a href="/books/n/hsnihcdc/A45562/" class="toc-item">25. Cervical Cancer Screening: the Pap Smear: National Institutes of Health Consensus Development Conference Statement, July 23-25, 1980</a><ul id="toc_lst_NBK15127_A45564" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A45564"><a href="/books/n/hsnihcdc/A45562/#A45564" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45578"><a href="/books/n/hsnihcdc/A45562/#A45578" class="toc-item">Does Screening With a Pap Smear Affect the Mortality From Cervical Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45580"><a href="/books/n/hsnihcdc/A45562/#A45580" class="toc-item">Is the Pap Smear Safe as a Screening Procedure?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45582"><a href="/books/n/hsnihcdc/A45562/#A45582" class="toc-item">On the Assumption That Screening Is Beneficial</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45599"><a href="/books/n/hsnihcdc/A45562/#A45599" class="toc-item">What Critical Factors Are Needed To Ensure That the Procedure Is Reliable?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45600"><a href="/books/n/hsnihcdc/A45562/#A45600" class="toc-item">Following a Screening What Are the Responsibilities for Followup, Confirmation of Findings, and Initiation of Treatment?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45603"><a href="/books/n/hsnihcdc/A45562/#A45603" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45648"><a href="/books/n/hsnihcdc/A45562/#A45648" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45827"><a href="/books/n/hsnihcdc/A45562/#A45827" class="toc-item">Conference Coordinators</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45834"><a href="/books/n/hsnihcdc/A45562/#A45834" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A45512"><a href="/books/n/hsnihcdc/A45512/" class="toc-item">24. Adjuvant Chemotherapy for Breast Cancer: National Institutes of Health Consensus Development Conference Statement, July 14-16, 1980</a><ul id="toc_lst_NBK15127_A45514" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A45514"><a href="/books/n/hsnihcdc/A45512/#A45514" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45520"><a href="/books/n/hsnihcdc/A45512/#A45520" class="toc-item">Have Clinical Trials Established the Efficacy of Adjuvant Chemotherapy of Breast Cancer?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45521"><a href="/books/n/hsnihcdc/A45512/#A45521" class="toc-item">Do the Benefits of Adjuvant Chemotherapy Clearly Outweigh the Risks?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45522"><a href="/books/n/hsnihcdc/A45512/#A45522" class="toc-item">Should Future Adjuvant Studies Include Hormonal Manipulations?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45523"><a href="/books/n/hsnihcdc/A45512/#A45523" class="toc-item">What Is the Role of Adjuvant Chemotherapy in Stage I Patients?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45524"><a href="/books/n/hsnihcdc/A45512/#A45524" class="toc-item">What Is the Role of Adjuvant Chemotherapy in Post-Menopausal Patients?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45525"><a href="/books/n/hsnihcdc/A45512/#A45525" class="toc-item">Consensus Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45558"><a href="/books/n/hsnihcdc/A45512/#A45558" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A45303"><a href="/books/n/hsnihcdc/A45303/" class="toc-item">23. Febrile Seizures: National Institutes of Health Consensus Development Conference Statement, May 19-21, 1980</a><ul id="toc_lst_NBK15127_A45305" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A45305"><a href="/books/n/hsnihcdc/A45303/#A45305" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45312"><a href="/books/n/hsnihcdc/A45303/#A45312" class="toc-item">What Is a Febrile Seizure?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45314"><a href="/books/n/hsnihcdc/A45303/#A45314" class="toc-item">What Are the Risks Facing the Child Who Has a Febrile Seizure?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45318"><a href="/books/n/hsnihcdc/A45303/#A45318" class="toc-item">What Can Chronic or Intermittent Prophylaxis Accomplish in Reducing Those Risks?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45322"><a href="/books/n/hsnihcdc/A45303/#A45322" class="toc-item">What Are the Potential Risks of Prophylaxis, Using the Available Forms of Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45329"><a href="/books/n/hsnihcdc/A45303/#A45329" class="toc-item">What Is a Rational Approach to Management of Children With Febrile Seizures? Which Children Should Be Considered for Prophylaxis?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45343"><a href="/books/n/hsnihcdc/A45303/#A45343" class="toc-item">Are Further Clinical, Experimental, or Epidemiologic Studies Necessary To Help in Answering These Questions?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45358"><a href="/books/n/hsnihcdc/A45303/#A45358" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45401"><a href="/books/n/hsnihcdc/A45303/#A45401" class="toc-item">Speakers</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45508"><a href="/books/n/hsnihcdc/A45303/#A45508" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A45204"><a href="/books/n/hsnihcdc/A45204/" class="toc-item">22. Thrombolytic Therapy in Thrombosis: National Institutes of Health Consensus Development Conference Statement, April 10-12, 1980</a><ul id="toc_lst_NBK15127_A45206" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A45206"><a href="/books/n/hsnihcdc/A45204/#A45206" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45220"><a href="/books/n/hsnihcdc/A45204/#A45220" class="toc-item">Are There Proven Benefits for the Use of Thrombolytic Therapy in Currently Approved Indications, i.e., the More Severe Forms of Acute Deep-Vein Thrombosis and Pulmonary Embolism?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45225"><a href="/books/n/hsnihcdc/A45204/#A45225" class="toc-item">What Are the Risks Associated With the Use of Thrombolytic Agents?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45228"><a href="/books/n/hsnihcdc/A45204/#A45228" class="toc-item">What Are the Guidelines for Patient Selection?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45246"><a href="/books/n/hsnihcdc/A45204/#A45246" class="toc-item">Assuming There Are Proven Benefits and a Favorable Risk/Benefit Ratio, Why Are These Drugs Not Being Used More Frequently?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45253"><a href="/books/n/hsnihcdc/A45204/#A45253" class="toc-item">What Are the Guidelines for Patient Management and Monitoring?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45261"><a href="/books/n/hsnihcdc/A45204/#A45261" class="toc-item">What Are the Economic Aspects Involved in Thrombolytic Therapy?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45262"><a href="/books/n/hsnihcdc/A45204/#A45262" class="toc-item">What Should Be the Direction for Future Clinical Research?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45263"><a href="/books/n/hsnihcdc/A45204/#A45263" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45299"><a href="/books/n/hsnihcdc/A45204/#A45299" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A45177"><a href="/books/n/hsnihcdc/A45177/" class="toc-item">21. Removal of Third Molars: National Institutes of Health Consensus Development Conference Statement, November 28-30, 1979</a><ul id="toc_lst_NBK15127_A45179" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A45179"><a href="/books/n/hsnihcdc/A45177/#A45179" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45185"><a href="/books/n/hsnihcdc/A45177/#A45185" class="toc-item">The Effect of Third Molar Removal on Growth and Development</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45186"><a href="/books/n/hsnihcdc/A45177/#A45186" class="toc-item">The Timing and Technical Considerations for Third Molar Removal</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45187"><a href="/books/n/hsnihcdc/A45177/#A45187" class="toc-item">Prosthodontic and Periodontic Considerations for Third Molar Removal</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45188"><a href="/books/n/hsnihcdc/A45177/#A45188" class="toc-item">The Morbidity of Third Molar Removal</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45189"><a href="/books/n/hsnihcdc/A45177/#A45189" class="toc-item">The Advantages and Disadvantages of Third Molar Removal</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45190"><a href="/books/n/hsnihcdc/A45177/#A45190" class="toc-item">Summary</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45191"><a href="/books/n/hsnihcdc/A45177/#A45191" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45201"><a href="/books/n/hsnihcdc/A45177/#A45201" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A45124"><a href="/books/n/hsnihcdc/A45124/" class="toc-item">20. Microprocessor-Based "Intelligent" Machines in Patient Care: National Institutes of Health Consensus Development Conference Statement, October 17-19, 1979</a><ul id="toc_lst_NBK15127_A45126" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A45126"><a href="/books/n/hsnihcdc/A45124/#A45126" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45147"><a href="/books/n/hsnihcdc/A45124/#A45147" class="toc-item">Consensus Development Panel 1</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45155"><a href="/books/n/hsnihcdc/A45124/#A45155" class="toc-item">Consensus Development Panel 2</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45163"><a href="/books/n/hsnihcdc/A45124/#A45163" class="toc-item">Consensus Development Panel 3</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45173"><a href="/books/n/hsnihcdc/A45124/#A45173" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A45065"><a href="/books/n/hsnihcdc/A45065/" class="toc-item">19. Amantadine: Does It Have a Role in the Prevention and Treatment of Influenza? National Institutes of Health Consensus Development Conference Statement, October 15-16, 1979</a><ul id="toc_lst_NBK15127_A45067" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A45067"><a href="/books/n/hsnihcdc/A45065/#A45067" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45073"><a href="/books/n/hsnihcdc/A45065/#A45073" class="toc-item">What Are Potential Benefits of Use of Amantadine Hydrochloride in the Treatment of Influenza Type A?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45074"><a href="/books/n/hsnihcdc/A45065/#A45074" class="toc-item">Who Should Take Amantadine and When Should It Be Taken?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45083"><a href="/books/n/hsnihcdc/A45065/#A45083" class="toc-item">What Are the Risks of the Use of Amantadine Hydrochloride in the Above-Described Fashions for the Prophylaxis and Treatment of Disease Caused By Influenza A Viruses?</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45087"><a href="/books/n/hsnihcdc/A45065/#A45087" class="toc-item">Role for Combined Use of Amantadine Hydrochloride and Influenza Immunization</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45088"><a href="/books/n/hsnihcdc/A45065/#A45088" class="toc-item">Conclusions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45092"><a href="/books/n/hsnihcdc/A45065/#A45092" class="toc-item">Unanswered Questions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45102"><a href="/books/n/hsnihcdc/A45065/#A45102" class="toc-item">Footnote</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45104"><a href="/books/n/hsnihcdc/A45065/#A45104" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45121"><a href="/books/n/hsnihcdc/A45065/#A45121" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A45059"><a href="/books/n/hsnihcdc/A45059/" class="toc-item">18. Estrogen Use and Postmenopausal Women: National Institutes of Health Consensus Development Conference Statement, September 13-14, 1979</a><ul id="toc_lst_NBK15127_A45061" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A45061"><a href="/books/n/hsnihcdc/A45059/#A45061" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45062"><a href="/books/n/hsnihcdc/A45059/#A45062" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A45007"><a href="/books/n/hsnihcdc/A45007/" class="toc-item">17. Intraocular Lens Implantation: National Institutes of Health Consensus Development Conference Statement, September 10-11, 1979</a><ul id="toc_lst_NBK15127_A45009" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A45009"><a href="/books/n/hsnihcdc/A45007/#A45009" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45010"><a href="/books/n/hsnihcdc/A45007/#A45010" class="toc-item">Lens Design and Manufacture</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45011"><a href="/books/n/hsnihcdc/A45007/#A45011" class="toc-item">Preoperative Evaluation of the Patient</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45012"><a href="/books/n/hsnihcdc/A45007/#A45012" class="toc-item">Indications and Contraindications for Intraocular Lens Implantation</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45029"><a href="/books/n/hsnihcdc/A45007/#A45029" class="toc-item">Method of Cataract Extraction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45030"><a href="/books/n/hsnihcdc/A45007/#A45030" class="toc-item">Experience to Date With Intraocular Lens Implantation</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45031"><a href="/books/n/hsnihcdc/A45007/#A45031" class="toc-item">Special Considerations in Intraocular Implantation</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45032"><a href="/books/n/hsnihcdc/A45007/#A45032" class="toc-item">Alternatives to Intraocular Lenses</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45033"><a href="/books/n/hsnihcdc/A45007/#A45033" class="toc-item">Studies Planned or in Progress</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45034"><a href="/books/n/hsnihcdc/A45007/#A45034" class="toc-item">Public Comments</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45047"><a href="/books/n/hsnihcdc/A45007/#A45047" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45048"><a href="/books/n/hsnihcdc/A45007/#A45048" class="toc-item">Panel Moderators</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45056"><a href="/books/n/hsnihcdc/A45007/#A45056" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44974"><a href="/books/n/hsnihcdc/A44974/" class="toc-item">16. Steroid Receptors in Breast Cancer: National Institutes of Health Consensus Development Conference Statement, June 27-29, 1979</a><ul id="toc_lst_NBK15127_A44976" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44976"><a href="/books/n/hsnihcdc/A44974/#A44976" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44989"><a href="/books/n/hsnihcdc/A44974/#A44989" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A45004"><a href="/books/n/hsnihcdc/A44974/#A45004" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44947"><a href="/books/n/hsnihcdc/A44947/" class="toc-item">15. The Treatment of Primary Breast Cancer: Management of Local Disease: National Institutes of Health Consensus Development Conference Statement, June 5, 1979</a><ul id="toc_lst_NBK15127_A44949" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44949"><a href="/books/n/hsnihcdc/A44947/#A44949" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44953"><a href="/books/n/hsnihcdc/A44947/#A44953" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44971"><a href="/books/n/hsnihcdc/A44947/#A44971" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44921"><a href="/books/n/hsnihcdc/A44921/" class="toc-item">14. Improving Clinical and Consumer Use of Blood Pressure Measuring Devices: National Institutes of Health Consensus Development Conference Statement, April 26-27, 1979</a><ul id="toc_lst_NBK15127_A44923" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44923"><a href="/books/n/hsnihcdc/A44921/#A44923" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44931"><a href="/books/n/hsnihcdc/A44921/#A44931" class="toc-item">Workshop Leaders</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44938"><a href="/books/n/hsnihcdc/A44921/#A44938" class="toc-item">Conference Sponsors</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44946"><a href="/books/n/hsnihcdc/A44921/#A44946" class="toc-item">Supplemental Information for NIH Consensus Statement on Improving Clinical and Consumer Use of Blood Pressure Monitoring Devices</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44903"><a href="/books/n/hsnihcdc/A44903/" class="toc-item">13. Transfusion Therapy in Pregnant Sickle Cell Disease Patients: National Institutes of Health Consensus Development Conference Statement, April 23-24, 1979</a><ul id="toc_lst_NBK15127_A44905" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44905"><a href="/books/n/hsnihcdc/A44903/#A44905" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44906"><a href="/books/n/hsnihcdc/A44903/#A44906" class="toc-item">Work Group I</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44907"><a href="/books/n/hsnihcdc/A44903/#A44907" class="toc-item">Work Group II</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44908"><a href="/books/n/hsnihcdc/A44903/#A44908" class="toc-item">Work Group III</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44912"><a href="/books/n/hsnihcdc/A44903/#A44912" class="toc-item">Work Group IV</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44913"><a href="/books/n/hsnihcdc/A44903/#A44913" class="toc-item">Consensus Development Panel Co-Chairmen</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44918"><a href="/books/n/hsnihcdc/A44903/#A44918" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44737"><a href="/books/n/hsnihcdc/A44737/" class="toc-item">12. Antenatal Diagnosis: National Institutes of Health Consensus Development Conference Statement, March 5-7, 1979</a><ul id="toc_lst_NBK15127_A44739" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44739"><a href="/books/n/hsnihcdc/A44737/#A44739" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44743"><a href="/books/n/hsnihcdc/A44737/#A44743" class="toc-item">Predictors of Hereditary Disease or Congenital Defects</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44751"><a href="/books/n/hsnihcdc/A44737/#A44751" class="toc-item">Predictors of Fetal Maturation</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44754"><a href="/books/n/hsnihcdc/A44737/#A44754" class="toc-item">Predictors of Fetal Distress</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44764"><a href="/books/n/hsnihcdc/A44737/#A44764" class="toc-item">Task Force on Predictors of Hereditary Disease or Congenital Defects</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44816"><a href="/books/n/hsnihcdc/A44737/#A44816" class="toc-item">Task Force on Predictors of Fetal Maturation</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44847"><a href="/books/n/hsnihcdc/A44737/#A44847" class="toc-item">Task Force on Predictors of Fetal Distress</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44899"><a href="/books/n/hsnihcdc/A44737/#A44899" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44699"><a href="/books/n/hsnihcdc/A44699/" class="toc-item">11. Pain, Discomfort, and Humanitarian Care: National Institutes of Health Consensus Development Conference Statement, February 16, 1979</a><ul id="toc_lst_NBK15127_A44701" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44701"><a href="/books/n/hsnihcdc/A44699/#A44701" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44713"><a href="/books/n/hsnihcdc/A44699/#A44713" class="toc-item">Consensus Development Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44726"><a href="/books/n/hsnihcdc/A44699/#A44726" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44693"><a href="/books/n/hsnihcdc/A44693/" class="toc-item">10. Surgical Treatment of Morbid Obesity: National Institutes of Health Consensus Development Conference Statement, December 4-5, 1978</a><ul id="toc_lst_NBK15127_A44695" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44695"><a href="/books/n/hsnihcdc/A44693/#A44695" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44696"><a href="/books/n/hsnihcdc/A44693/#A44696" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44687"><a href="/books/n/hsnihcdc/A44687/" class="toc-item">9. Supportive Therapy in Burn Care: National Institutes of Health Consensus Development Conference Statement, November 10-11, 1978</a><ul id="toc_lst_NBK15127_A44689" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44689"><a href="/books/n/hsnihcdc/A44687/#A44689" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44690"><a href="/books/n/hsnihcdc/A44687/#A44690" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44674"><a href="/books/n/hsnihcdc/A44674/" class="toc-item">8. Mass Screening for Lung Cancer: National Institutes of Health Consensus Development Conference Statement, September 18-20, 1978</a><ul id="toc_lst_NBK15127_A44676" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44676"><a href="/books/n/hsnihcdc/A44674/#A44676" class="toc-item">Note</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44684"><a href="/books/n/hsnihcdc/A44674/#A44684" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44660"><a href="/books/n/hsnihcdc/A44660/" class="toc-item">7. Availability of Insect Sting Kits to Non-Physicians: National Institutes of Health Consensus Development Conference Statement, September 14, 1978</a><ul id="toc_lst_NBK15127_A44662" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44662"><a href="/books/n/hsnihcdc/A44660/#A44662" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44671"><a href="/books/n/hsnihcdc/A44660/#A44671" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44640"><a href="/books/n/hsnihcdc/A44640/" class="toc-item">6. Indications for Tonsillectomy and Adenoidectomy Phase I: National Institutes of Health Consensus Development Conference Statement, July 20, 1978</a><ul id="toc_lst_NBK15127_A44642" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44642"><a href="/books/n/hsnihcdc/A44640/#A44642" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44648"><a href="/books/n/hsnihcdc/A44640/#A44648" class="toc-item">The Report's Summary</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44657"><a href="/books/n/hsnihcdc/A44640/#A44657" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44621"><a href="/books/n/hsnihcdc/A44621/" class="toc-item">5. Treatable Brain Diseases in the Elderly: National Institutes of Health Consensus Development Conference Statement, July 10-11, 1978</a><ul id="toc_lst_NBK15127_A44623" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44623"><a href="/books/n/hsnihcdc/A44621/#A44623" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44637"><a href="/books/n/hsnihcdc/A44621/#A44637" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44586"><a href="/books/n/hsnihcdc/A44586/" class="toc-item">4. Mass Screening for Colo-Rectal Cancer: National Institutes of Health Consensus Development Conference Statement, June 26-28, 1978</a><ul id="toc_lst_NBK15127_A44588" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44588"><a href="/books/n/hsnihcdc/A44586/#A44588" class="toc-item">Conference Report</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44618"><a href="/books/n/hsnihcdc/A44586/#A44618" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44518"><a href="/books/n/hsnihcdc/A44518/" class="toc-item">3. Dental Implants: Benefit and Risk: National Institutes of Health Consensus Development Conference Statement, June 13-14, 1978</a><ul id="toc_lst_NBK15127_A44520" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44520"><a href="/books/n/hsnihcdc/A44518/#A44520" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44521"><a href="/books/n/hsnihcdc/A44518/#A44521" class="toc-item">Definition of Success</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44523"><a href="/books/n/hsnihcdc/A44518/#A44523" class="toc-item">The Interpretation of Survival Statistics</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44531"><a href="/books/n/hsnihcdc/A44518/#A44531" class="toc-item">Guidelines for Current Use</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44533"><a href="/books/n/hsnihcdc/A44518/#A44533" class="toc-item">Subperiosteal and Staple/Transosteal</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44538"><a href="/books/n/hsnihcdc/A44518/#A44538" class="toc-item">Vitreous Carbon and Blade</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44542"><a href="/books/n/hsnihcdc/A44518/#A44542" class="toc-item">Complications and Removal Criteria</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44544"><a href="/books/n/hsnihcdc/A44518/#A44544" class="toc-item">Required Patient Information</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44551"><a href="/books/n/hsnihcdc/A44518/#A44551" class="toc-item">Evaluation Criteria</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44581"><a href="/books/n/hsnihcdc/A44518/#A44581" class="toc-item">Future Directions</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44583"><a href="/books/n/hsnihcdc/A44518/#A44583" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44499"><a href="/books/n/hsnihcdc/A44499/" class="toc-item">2. Educational Needs of Physicians and Public Regarding Asbestos Exposure: National Institutes of Health Consensus Development Conference Statement, May 22, 1978</a><ul id="toc_lst_NBK15127_A44501" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44501"><a href="/books/n/hsnihcdc/A44499/#A44501" class="toc-item">Introduction</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44514"><a href="/books/n/hsnihcdc/A44499/#A44514" class="toc-item">Conference Sponsors</a></li></ul></li><li class="half_rhythm" id="toc_itm_NBK15127_A44430"><a href="/books/n/hsnihcdc/A44430/" class="toc-item">1. Breast Cancer Screening: National Institutes of Health Consensus Development Conference Statement, September 14-16, 1977</a><ul id="toc_lst_NBK15127_A44432" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK15127_A44432"><a href="/books/n/hsnihcdc/A44430/#A44432" class="toc-item">Issues and Recommendations</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44447"><a href="/books/n/hsnihcdc/A44430/#A44447" class="toc-item">Conference Panel</a></li><li class="half_rhythm" id="toc_itm_NBK15127_A44495"><a href="/books/n/hsnihcdc/A44430/#A44495" class="toc-item">Conference Sponsors</a></li></ul></li></ul><div class="bktoc_all_cntnr align_right" style="display:none"><ul class="inline_list_right"><li><a class="bktoc_all_exp" href="#">Expand All</a></li><li style="margin-left:.8em"><a class="bktoc_all_clps" href="#">Collapse All</a></li></ul></div></div></div></div>
|
|
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK15127</span></div><div style="margin-top:2em" class="bk_noprnt"><div class="pagination bk_noprnt"><span class="inactive page_link prev">< Prev</span><a class="active page_link next" href="/books/n/hsnihcdc/A22074/" title="Next page in this title">Next ></a></div></div></div></div>
|
|
|
|
</div>
|
|
|
|
<!-- Custom content below content -->
|
|
<div class="col4">
|
|
|
|
</div>
|
|
|
|
|
|
<!-- Book content -->
|
|
|
|
<!-- Custom contetnt below bottom nav -->
|
|
<div class="col5">
|
|
|
|
</div>
|
|
</div>
|
|
|
|
<div id="rightcolumn" class="four_col col last">
|
|
<!-- Custom content above discovery portlets -->
|
|
<div class="col6">
|
|
<div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK15127&db=books">Share</a></div>
|
|
|
|
</div>
|
|
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK15127/?report=reader">PubReader</a></li><li><a href="/books/NBK15127/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK15127" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK15127" style="display:none" title="Cite this Page"><div class="bk_tt">National Institutes of Health (US). Office for Medical Applications of Research. NIH Consensus Statements [Internet]. Bethesda (MD): National Institutes of Health (US); 1977-2002. <span class="bk_cite_avail"></span></div></div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Other titles in this collection</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/hstatcollect/">Health Services/Technology Assessment
|
|
Text (HSTAT)</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=67d5cc6b67c23b31e0a3558e">NIH Consensus Statements</a><div class="ralinkpop offscreen_noflow">NIH Consensus Statements<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=67d5cc6a2f30673f7be63e23">Minnesota Health Technology Assessments</a><div class="ralinkpop offscreen_noflow">Minnesota Health Technology Assessments<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=67d5cc6867c23b31e0a34e3e">The Guide to Community Preventive Services</a><div class="ralinkpop offscreen_noflow">The Guide to Community Preventive Services<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=67d5cc6767c23b31e0a34d13">Clinician's Handbook of Preventive Services</a><div class="ralinkpop offscreen_noflow">Clinician's Handbook of Preventive Services<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=67d5cc6667c23b31e0a34721">ClinicalInfo.HIV.gov</a><div class="ralinkpop offscreen_noflow">ClinicalInfo.HIV.gov<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
|
|
|
|
<!-- Custom content below discovery portlets -->
|
|
<div class="col7">
|
|
|
|
</div>
|
|
</div>
|
|
</div>
|
|
|
|
<!-- Custom content after all -->
|
|
<div class="col8">
|
|
|
|
</div>
|
|
<div class="col9">
|
|
|
|
</div>
|
|
|
|
<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
|
|
<script type="text/javascript">
|
|
(function($){
|
|
$('.skiplink').each(function(i, item){
|
|
var href = $($(item).attr('href'));
|
|
href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
|
|
$(item).on('click', function(event){
|
|
event.preventDefault();
|
|
$.scrollTo(href, 0, {
|
|
onAfter: function(){
|
|
href.focus();
|
|
}
|
|
});
|
|
});
|
|
});
|
|
})(jQuery);
|
|
</script>
|
|
</div>
|
|
<div class="bottom">
|
|
|
|
<div id="NCBIFooter_dynamic">
|
|
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
|
<component id="Breadcrumbs" label="helpdesk"/>-->
|
|
|
|
</div>
|
|
|
|
<div class="footer" id="footer">
|
|
<section class="icon-section">
|
|
<div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
|
|
<div class="grid-container container">
|
|
<div class="icon-section_container">
|
|
<a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
|
<defs>
|
|
<style>
|
|
.cls-11 {
|
|
fill: #737373;
|
|
}
|
|
</style>
|
|
</defs>
|
|
<title>Twitter</title>
|
|
<path class="cls-11" d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
|
|
</path>
|
|
</svg></a>
|
|
<a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
|
<title>Facebook</title>
|
|
<path class="cls-11" d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
|
|
</path>
|
|
</svg></a>
|
|
<a class="footer-icon" id="footer_linkedin" href="https://www.linkedin.com/company/ncbinlm" aria-label="LinkedIn"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
|
<title>LinkedIn</title>
|
|
<path class="cls-11" d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
|
|
</path>
|
|
</svg></a>
|
|
<a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
|
<defs>
|
|
<style>
|
|
.cls-11,
|
|
.cls-12 {
|
|
fill: #737373;
|
|
}
|
|
|
|
.cls-11 {
|
|
fill-rule: evenodd;
|
|
}
|
|
</style>
|
|
</defs>
|
|
<title>GitHub</title>
|
|
<path class="cls-11" d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
|
|
</path>
|
|
<path class="cls-12" d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
|
|
</path>
|
|
<path class="cls-12" d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
|
|
</path>
|
|
<path class="cls-12" d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
|
|
<path class="cls-12" d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
|
|
</path>
|
|
<path class="cls-12" d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
|
|
</path>
|
|
<path class="cls-12" d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
|
|
</path>
|
|
<path class="cls-12" d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
|
|
</svg></a>
|
|
<a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
|
|
<svg xmlns="http://www.w3.org/2000/svg" id="Layer_1" data-name="Layer 1" viewBox="0 0 40 40">
|
|
<defs><style>.cls-1{fill:#737373;}</style></defs>
|
|
<title>NCBI Insights Blog</title>
|
|
<path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"></path>
|
|
</svg>
|
|
</a>
|
|
</div>
|
|
</div>
|
|
</section>
|
|
|
|
<section class="container-fluid bg-primary">
|
|
<div class="container pt-5">
|
|
<div class="row mt-3">
|
|
<div class="col-lg-3 col-12">
|
|
<p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
|
|
<ul class="list-inline social_media">
|
|
<li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter" target="_blank" rel="noopener noreferrer"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
|
<style type="text/css">
|
|
.st20 {
|
|
fill: #FFFFFF;
|
|
}
|
|
|
|
.st30 {
|
|
fill: none;
|
|
stroke: #FFFFFF;
|
|
stroke-width: 8;
|
|
stroke-miterlimit: 10;
|
|
}
|
|
</style>
|
|
<title>Twitter</title>
|
|
<g>
|
|
<g>
|
|
<g>
|
|
<path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7 c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116 c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3 c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6 C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
|
|
</g>
|
|
</g>
|
|
<circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
|
|
</g>
|
|
</svg></a></li>
|
|
<li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine" aria-label="Facebook" rel="noopener noreferrer" target="_blank">
|
|
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
|
<style type="text/css">
|
|
.st10 {
|
|
fill: #FFFFFF;
|
|
}
|
|
|
|
.st110 {
|
|
fill: none;
|
|
stroke: #FFFFFF;
|
|
stroke-width: 8;
|
|
stroke-miterlimit: 10;
|
|
}
|
|
</style>
|
|
<title>Facebook</title>
|
|
<g>
|
|
<g>
|
|
<path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9 v67.5H135v-67.5h21.7L159,99.1z"></path>
|
|
</g>
|
|
</g>
|
|
<circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
|
|
</svg>
|
|
</a></li>
|
|
<li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube" target="_blank" rel="noopener noreferrer"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
|
<title>Youtube</title>
|
|
<style type="text/css">
|
|
.st4 {
|
|
fill: none;
|
|
stroke: #FFFFFF;
|
|
stroke-width: 8;
|
|
stroke-miterlimit: 10;
|
|
}
|
|
|
|
.st5 {
|
|
fill: #FFFFFF;
|
|
}
|
|
</style>
|
|
<circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
|
|
<g transform="translate(0,-952.36218)">
|
|
<path class="st5" d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7 v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
|
|
</g>
|
|
</svg></a></li>
|
|
</ul>
|
|
</div>
|
|
<div class="col-lg-3 col-12">
|
|
<p class="address_footer text-white">National Library of Medicine<br />
|
|
<a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323" class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br />
|
|
Bethesda, MD 20894</a></p>
|
|
</div>
|
|
<div class="col-lg-3 col-12 centered-lg">
|
|
<p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br />
|
|
<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="text-white">FOIA</a><br />
|
|
<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
|
|
</div>
|
|
<div class="col-lg-3 col-12 centered-lg">
|
|
<p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br />
|
|
<a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br />
|
|
<a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
|
|
</div>
|
|
</div>
|
|
<div class="row">
|
|
<div class="col-lg-12 centered-lg">
|
|
<nav class="bottom-links">
|
|
<ul class="mt-3">
|
|
<li>
|
|
<a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
|
|
</li>
|
|
<li>
|
|
<a class="text-white" href="https://www.nih.gov/">NIH</a>
|
|
</li>
|
|
<li>
|
|
<a class="text-white" href="https://www.hhs.gov/">HHS</a>
|
|
</li>
|
|
<li>
|
|
<a class="text-white" href="https://www.usa.gov/">USA.gov</a>
|
|
</li>
|
|
</ul>
|
|
</nav>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
</section>
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
<!--/.page-->
|
|
</div>
|
|
<!--/.wrap-->
|
|
</div><!-- /.twelve_col -->
|
|
</div>
|
|
<!-- /.grid -->
|
|
|
|
<span class="PAFAppResources"></span>
|
|
|
|
<!-- BESelector tab -->
|
|
|
|
|
|
|
|
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-toc&ncbi_acc=NBK15127&ncbi_domain=hsnihcdc&ncbi_report=record&ncbi_type=fulltext&ncbi_objectid=&ncbi_pcid=/NBK15127/&ncbi_pagename=NIH Consensus Statements - NCBI Bookshelf&ncbi_bookparttype=toc&ncbi_app=bookshelf" /></noscript>
|
|
|
|
|
|
<!-- usually for JS scripts at page bottom -->
|
|
<!--<component id="PageFixtures" label="styles"></component>-->
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal107 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4209313/4212053/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
|
|
</html> |